SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2003
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 |
For the transition period from ________________ to ________________
Commission file number: 000-33291
NASSDA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
77-0494462 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
2650 San Tomas Expressway, Santa Clara CA 95051-0953
(Address of Principal Executive Offices) (Zip Code)
Registrants telephone number, including area code: (408) 988-9988
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended). Yes x No ¨
At April 30, 2003, 25,662,486 shares of common stock of the Registrant were outstanding.
INDEX
PART I. |
FINANCIAL INFORMATION |
PAGE NO. | ||
Item 1. |
3 | |||
3 | ||||
4 | ||||
5 | ||||
6-13 | ||||
Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations |
14-41 | ||
Item 3. |
41 | |||
Item 4. |
42 | |||
PART II. |
OTHER INFORMATION |
|||
Item 1. |
42-44 | |||
Item 4. |
45 | |||
Item 6. |
45 | |||
46 |
2
PART IFINANCIAL INFORMATION
ITEM 1: | FINANCIAL STATEMENTS |
NASSDA CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
March 31, 2003 |
September 30, 2002 (1) |
|||||||
(unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
47,418 |
|
$ |
43,157 |
| ||
Short-term investments |
|
37,590 |
|
|
35,295 |
| ||
Accounts receivable, net of allowances $73 and $87 at March 31, 2003 and September 30, 2002, respectively |
|
2,927 |
|
|
4,156 |
| ||
Prepaid expenses and other current assets |
|
1,438 |
|
|
553 |
| ||
Deferred income taxes |
|
2,405 |
|
|
2,050 |
| ||
Total current assets |
|
91,778 |
|
|
85,211 |
| ||
Property and equipment, net |
|
921 |
|
|
784 |
| ||
Other assets |
|
638 |
|
|
727 |
| ||
Total assets |
$ |
93,337 |
|
$ |
86,722 |
| ||
Liabilities and Stockholders Equity: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ |
51 |
|
$ |
555 |
| ||
Accrued liabilities |
|
6,404 |
|
|
6,994 |
| ||
Deferred revenue |
|
7,452 |
|
|
6,065 |
| ||
Total current liabilities |
|
13,907 |
|
|
13,614 |
| ||
Long-term liabilities |
|
119 |
|
|
54 |
| ||
Total liabilities |
|
14,026 |
|
|
13,668 |
| ||
Stockholders equity: |
||||||||
Common stock, par value $0.001: 110,000,000 shares authorized; 25,512,938 and 24,935,036 shares outstanding at March 31, 2003 and September 30, 2002, respectively |
|
25 |
|
|
25 |
| ||
Additional paid-in capital |
|
69,089 |
|
|
66,378 |
| ||
Deferred stock-based compensation |
|
(1,711 |
) |
|
(2,208 |
) | ||
Accumulated other comprehensive income |
|
10 |
|
|
6 |
| ||
Retained earnings |
|
11,898 |
|
|
8,853 |
| ||
Total stockholders equity |
|
79,311 |
|
|
73,054 |
| ||
Total liabilities and stockholders equity |
$ |
93,337 |
|
$ |
86,722 |
| ||
(1) | Derived from the audited consolidated balance sheet of Nassda Corporation as of September 30, 2002 |
See accompanying notes to condensed consolidated financial statements.
3
NASSDA CORPORATION
CONDENSED CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share data)
Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||||||
2003 |
2002 |
2003 |
2002 |
|||||||||||||
(unaudited) |
||||||||||||||||
Revenue: |
||||||||||||||||
Product |
$ |
3,211 |
|
$ |
4,408 |
|
$ |
7,843 |
|
$ |
8,921 |
| ||||
Subscription |
|
3,443 |
|
|
2,450 |
|
|
7,191 |
|
|
4,040 |
| ||||
Maintenance |
|
2,145 |
|
|
1,163 |
|
|
4,100 |
|
|
2,152 |
| ||||
Total revenue |
|
8,799 |
|
|
8,021 |
|
|
19,134 |
|
|
15,113 |
| ||||
Cost of revenue: |
||||||||||||||||
Product |
|
63 |
|
|
55 |
|
|
129 |
|
|
135 |
| ||||
Subscription |
|
84 |
|
|
67 |
|
|
170 |
|
|
117 |
| ||||
Maintenance |
|
197 |
|
|
156 |
|
|
398 |
|
|
313 |
| ||||
Total cost of revenue |
|
344 |
|
|
278 |
|
|
697 |
|
|
565 |
| ||||
Gross profit |
|
8,455 |
|
|
7,743 |
|
|
18,437 |
|
|
14,548 |
| ||||
Operating expenses: |
||||||||||||||||
Research and development |
|
1,706 |
|
|
1,274 |
|
|
3,235 |
|
|
2,585 |
| ||||
Sales and marketing |
|
2,873 |
|
|
2,292 |
|
|
5,749 |
|
|
4,410 |
| ||||
General and administrative |
|
2,414 |
|
|
1,857 |
|
|
4,878 |
|
|
3,522 |
| ||||
Stock-based compensation* |
|
248 |
|
|
252 |
|
|
496 |
|
|
504 |
| ||||
Total operating expenses |
|
7,241 |
|
|
5,675 |
|
|
14,358 |
|
|
11,021 |
| ||||
Income from operations |
|
1,214 |
|
|
2,068 |
|
|
4,079 |
|
|
3,527 |
| ||||
Interest income |
|
256 |
|
|
216 |
|
|
524 |
|
|
335 |
| ||||
Other income (expense), net |
|
(10 |
) |
|
(2 |
) |
|
(30 |
) |
|
(5 |
) | ||||
Income before taxes |
|
1,460 |
|
|
2,282 |
|
|
4,573 |
|
|
3,857 |
| ||||
Provision for taxes |
|
(438 |
) |
|
(890 |
) |
|
(1,528 |
) |
|
(1,444 |
) | ||||
Net income |
$ |
1,022 |
|
$ |
1,392 |
|
$ |
3,045 |
|
$ |
2,413 |
| ||||
Earnings per share: |
||||||||||||||||
Basic |
$ |
0.04 |
|
$ |
0.06 |
|
$ |
0.12 |
|
$ |
0.14 |
| ||||
Diluted |
$ |
0.04 |
|
$ |
0.05 |
|
$ |
0.11 |
|
$ |
0.09 |
| ||||
Shares used in computing earnings per share: |
||||||||||||||||
Basic |
|
24,889 |
|
|
22,034 |
|
|
24,626 |
|
|
16,902 |
| ||||
Diluted |
|
28,487 |
|
|
28,977 |
|
|
28,705 |
|
|
26,460 |
| ||||
* Stock-based compensation includes: |
||||||||||||||||
Research and development |
$ |
107 |
|
$ |
107 |
|
$ |
214 |
|
$ |
214 |
| ||||
Sales and marketing |
|
83 |
|
|
87 |
|
|
166 |
|
|
174 |
| ||||
General and administrative |
|
58 |
|
|
58 |
|
|
116 |
|
|
116 |
| ||||
Total |
$ |
248 |
|
$ |
252 |
|
$ |
496 |
|
$ |
504 |
| ||||
See accompanying notes to condensed consolidated financial statements.
4
NASSDA CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Six Months Ended March 31, |
||||||||
2003 |
2002 |
|||||||
(unaudited) |
||||||||
Operating activities |
||||||||
Net income |
$ |
3,045 |
|
$ |
2,413 |
| ||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
|
245 |
|
|
203 |
| ||
Stock-based compensation |
|
496 |
|
|
504 |
| ||
Deferred income taxes |
|
(273 |
) |
|
312 |
| ||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
|
1,229 |
|
|
(725 |
) | ||
Prepaid expenses and other current assets |
|
(885 |
) |
|
162 |
| ||
Accounts payable |
|
(504 |
) |
|
269 |
| ||
Accrued liabilities |
|
797 |
|
|
1,147 |
| ||
Deferred revenue |
|
1,387 |
|
|
(587 |
) | ||
Long-term liabilities |
|
65 |
|
|
(1,399 |
) | ||
Net cash provided by operating activities |
|
5,602 |
|
|
2,299 |
| ||
Investing activities |
||||||||
Purchase of short-term investments |
|
(35,518 |
) |
|
(18,298 |
) | ||
Proceeds from maturity of short-term investments |
|
33,234 |
|
|
13,565 |
| ||
Purchases of property and equipment |
|
(382 |
) |
|
(161 |
) | ||
Other assets |
|
(1 |
) |
|
41 |
| ||
Net cash used in investing activities |
|
(2,667 |
) |
|
(4,853 |
) | ||
Financing activities |
||||||||
Proceeds from issuance of common stock |
|
1,326 |
|
|
57,197 |
| ||
Repurchase of common stock |
|
|
|
|
(168 |
) | ||
Net cash provided by financing activities |
|
1,326 |
|
|
57,029 |
| ||
Increase in cash and cash equivalents |
|
4,261 |
|
|
54,475 |
| ||
Cash and cash equivalents, beginning of period |
|
43,157 |
|
|
5,655 |
| ||
Cash and cash equivalents, end of period |
$ |
47,418 |
|
$ |
60,130 |
| ||
Supplemental disclosure of cash flow information |
||||||||
Cash paid for income taxes |
$ |
|
|
$ |
1,139 |
| ||
Supplemental schedule of noncash activities |
||||||||
Unrealized gain/(loss) on short-term investments |
$ |
4 |
|
$ |
(45 |
) | ||
Deferred stock-based compensation (reversal) |
$ |
|
|
$ |
(189 |
) | ||
See accompanying notes to condensed consolidated financial statements.
5
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. | Basis of Presentation |
The Company
The interim condensed consolidated financial statements included herein have been prepared by Nassda Corporation, without audit pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The interim consolidated financial statements reflect, in the opinion of management, all adjustments necessary (consisting only of normal recurring adjustments) to present a fair statement of results for the interim periods presented. The operating results for any interim period are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2003. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2002.
Use of Estimates
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the interim financial statements and the reported amounts revenues and expenses during the reporting period. Actual results could differ from these estimates.
2. | Initial Public Offering |
We commenced our initial public offering in which we sold five million shares of common stock at $11.00 per share in December 2001. The net proceeds we received from this offering after deducting underwriting discounts and offering expenses were approximately $49.6 million. All outstanding shares of preferred stock were automatically converted into common stock on a share for share basis immediately prior to the first closing of the sale of our comment stock in the initial public offering. Our common stock began trading on the Nasdaq National Market on December 13, 2001.
In January 2002, the underwriters of our initial public offering exercised their over-allotment option to purchase an additional 750,000 shares of common stock at $11.00 per share. The net proceeds we received pursuant to this over-allotment option after deducting underwriting discounts were approximately $7.6 million.
3. | Earnings Per Share |
Basic earnings per share (EPS) is computed by dividing net income by the weighted average common shares outstanding of the period. Diluted EPS reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock.
During the three and six months ended March 31, 2003, we had securities outstanding that could potentially dilute basic earnings per share in the future, but these securities were excluded in the computation
6
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
of diluted earnings per share in such periods as their effect would have been antidilutive. At March 31, 2003, options to purchase 2.2 million shares of common stock with a weighted average exercise price of $9.95 per share were excluded from the diluted net income per share computation. We had no antidilutive shares during the three and six months ended March 31, 2002.
The following table is a reconciliation of the numerators and denominators used in computing basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||||||
2003 |
2002 |
2003 |
2002 |
|||||||||||||
Net income (numerator): |
$ |
1,022 |
|
$ |
1,392 |
|
$ |
3,045 |
|
$ |
2,413 |
| ||||
Shares (denominator): |
||||||||||||||||
Weighted average common shares outstanding |
|
25,473 |
|
|
24,258 |
|
|
25,327 |
|
|
19,407 |
| ||||
Weighted average common shares subject to repurchase |
|
(584 |
) |
|
(2,224 |
) |
|
(701 |
) |
|
(2,505 |
) | ||||
Shares used in basic computation |
|
24,889 |
|
|
22,034 |
|
|
24,626 |
|
|
16,902 |
| ||||
Weighted average common shares subject to repurchase |
|
584 |
|
|
2,224 |
|
|
701 |
|
|
2,505 |
| ||||
Common shares issuable upon exercise of stock options (treasury stock method) |
|
3,014 |
|
|
4,719 |
|
|
3,378 |
|
|
4,444 |
| ||||
Convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
2,609 |
| ||||
Shares used in diluted computation |
|
28,487 |
|
|
28,977 |
|
|
28,705 |
|
|
26,460 |
| ||||
Basic earnings per share |
$ |
0.04 |
|
$ |
0.06 |
|
$ |
0.12 |
|
$ |
0.14 |
| ||||
Diluted earnings per share |
$ |
0.04 |
|
$ |
0.05 |
|
$ |
0.11 |
|
$ |
0.09 |
| ||||
4. | Comprehensive Income |
The components of comprehensive income, net of tax, were as follows (in thousands):
Three Months Ended March 31, |
Six Months Ended March 31, |
||||||||||||||
2003 |
2002 |
2003 |
2002 |
||||||||||||
Net income |
$ |
1,022 |
|
$ |
1,392 |
|
$ |
3,045 |
$ |
2,413 |
| ||||
Unrealized gain/ (loss) on investments |
|
(6 |
) |
|
(34 |
) |
|
4 |
|
(45 |
) | ||||
Comprehensive Income |
$ |
1,016 |
|
$ |
1,358 |
|
$ |
3,049 |
$ |
2,368 |
| ||||
5. | Bonus and Management Compensation |
During fiscal 2001, we accrued bonuses of $3.7 million earned by our employees. We paid approximately $2.0 million of these bonuses during fiscal 2002, with the majority of the amount paid in the first quarter of fiscal 2002. In the first two quarters of fiscal 2003, we paid $1.4 million of these bonuses with the remainder to be paid ratably over the balance of fiscal 2003. Employees whose employment by us terminates prior to the applicable payment date will receive the undistributed amounts on December 15, 2005.
7
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
During fiscal 2002, we accrued bonuses of $760,000 earned by our employees. We anticipate that approximately $709,000 of these bonuses will be paid during fiscal 2003 and the remaining $51,000 will be paid during the first quarter of fiscal 2004. In the first two fiscal quarters of fiscal 2003, we paid $413,000 of these bonuses, with the remainder to be paid ratably over the balance of fiscal 2003 and the first quarter of 2004. As of March 31, 2003, none of these bonuses was classified as a long-term liability. Employees whose employment by us terminates prior to the applicable payment date will receive the undistributed amounts on December 15, 2006.
In addition, our executive officers orally agreed that they would not receive their base salaries in fiscal 2002 and fiscal 2003. The total base salaries earned by these executive officers in fiscal 2001 were approximately $539,000. As a result of our significant bonus accruals in fiscal 2001 and fiscal 2002 and the foregone salaries in fiscal 2002 and fiscal 2003, our compensation expense in fiscal 2004 may not be consistent with compensation expense in fiscal 2001, fiscal 2002 or fiscal 2003.
6. | Lease Commitments |
We lease our facilities under various noncancelable operating leases, which expired beginning in February 2003. Rent expense was $365,000 in fiscal 2001 and $600,000 in fiscal 2002. As of September 30, 2002, the aggregate future noncancelable minimum rentals or operating leases are as follows (in thousands):
Year Ending September 30, |
|||
2003 |
$ |
417 | |
2004 |
|
16 | |
2005 |
|
2 | |
$ |
435 | ||
In December 2002, we entered into a three-year operating lease beginning in February 2003. The lease is for our primary business operation. The future minimum lease obligations related to this lease are $982,000.
7. | Stock-based Awards |
We account for our stock-based awards to employees using the intrinsic value method in accordance with Accounting Principles Board No. 25, Accounting for Stock Issued to Employees, and its related interpretations. Accordingly, compensation expense has been recognized in the financial statements for employee stock arrangements to the extent the fair value of the underlying common stock exceeds the exercise price of the stock options at the date of grant. Deferred stock-based compensation of $2.5 million and $1.8 million was recorded during fiscal 2001 and fiscal 2000, respectively, for the excess of the fair value of the common stock underlying the options at the grant date over the exercise price of the options. These amounts are being amortized on a straight-line basis over the vesting period, generally four years. Amortization of deferred compensation related to employee grants was $496,000 and $504,000 for the six months ended March 31, 2003 and 2002, respectively.
8
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
We account for stock-based awards to non-employees in accordance with the provisions of Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation. Accordingly, we recognize the fair value for non-employee awards as stock compensation expense over the vesting terms of the awards. There were no stock-based awards to non-employees or amortization of stock compensation expenses recognized previously for non-employees during the six months ended March 31, 2003 and 2002.
SFAS No. 148 amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. With the adoption of SFAS No. 148, we are required to disclose pro forma information regarding option grants made to our employees based on specified valuation techniques that produce estimated compensation charges. Our calculations are based on a single option valuation approach and forfeitures are recognized as they occur. The fair value of options at the date of grant was estimated using the minimal value method for fiscal 2000, fiscal 2001 and through the date of our initial public offering in December 2001, and the Black-Scholes option pricing model for options granted thereafter, with the following weighted-average assumptions:
Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||
2003 |
2002 |
2003 |
2002 |
|||||||||
Stock Option Plans: |
||||||||||||
Risk-free interest rate |
3.0 |
% |
4.0 |
% |
3.0 |
% |
4.0 |
% | ||||
Expected volatility |
90.0 |
% |
70.0 |
% |
90.0 |
% |
70.0 |
% | ||||
Expected life (in years) |
4.5 |
|
4.5 |
|
4.5 |
|
4.5 |
| ||||
Expected dividend |
0.0 |
% |
0.0 |
% |
0.0 |
% |
0.0 |
% | ||||
Employee Stock Purchase Plan: |
||||||||||||
Risk-free interest rate |
1.39 |
% |
1.86 |
% |
1.39 |
% |
1.86 |
% | ||||
Expected volatility |
90.0 |
% |
70.0 |
% |
90.0 |
% |
70.0 |
% | ||||
Expected life (in years) |
2.0 |
|
2.0 |
|
2.0 |
|
2.0 |
| ||||
Expected dividend |
0.0 |
% |
0.0 |
% |
0.0 |
% |
0.0 |
% | ||||
If the computed minimum values of our stock-based awards to employees had been amortized to expense over the period of the awards as specified under SFAS No. 123, our pro forma net income (loss), basic income (loss) per share and diluted income (loss) per share under SFAS No. 123 (as compared to such items as reported) would have been as follows (in thousands, except per share amounts):
Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||||||
2003 |
2002 |
2003 |
2002 |
|||||||||||||
Net income as reported |
$ |
1,022 |
|
$ |
1,392 |
|
$ |
3,045 |
|
$ |
2,413 |
| ||||
Add: stock-based employee compensation expense included in reported net income, net of taxes |
|
205 |
|
|
252 |
|
|
396 |
|
|
504 |
| ||||
Less: stock-based employee compensation expense determined under fair value based method, net of taxes |
|
(1,363 |
) |
|
(805 |
) |
|
(2,690 |
) |
|
(1,413 |
) | ||||
Pro forma net income (loss) |
$ |
(136 |
) |
$ |
839 |
|
$ |
751 |
|
$ |
1,504 |
| ||||
Basic income (loss) per share: |
||||||||||||||||
As reported |
$ |
0.04 |
|
$ |
0.06 |
|
$ |
0.12 |
|
$ |
0.14 |
| ||||
Pro forma |
$ |
(0.01 |
) |
$ |
0.04 |
|
$ |
0.03 |
|
$ |
0.09 |
| ||||
Diluted income (loss) per share: |
||||||||||||||||
As reported |
$ |
0.04 |
|
$ |
0.05 |
|
$ |
0.11 |
|
$ |
0.09 |
| ||||
Pro forma |
$ |
(0.01 |
) |
$ |
0.03 |
|
$ |
0.03 |
|
$ |
0.06 |
| ||||
9
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
8. | Contingencies |
Legal Proceedings
Synopsys has filed claims against us in state and federal court. These claims are based on the alleged facts and circumstances relating to the departure of our five founders from their employment at Synopsys, the founding of our company and the development and sale of HSIM and our other products. Each of our founders and Dr. Sang S. Wang, our Chief Executive Officer, became an employee of Synopsys when Synopsys acquired EPIC Design Technology in February 1997. Dr. Wang resigned from Synopsys in March 1998 and served as a consultant to Synopsys until June 1998. Dr. An-Chang Deng, our President, and our four other founders resigned from Synopsys at approximately the same time in August 1998 and became employees of our company immediately thereafter. Dr. Wang became an employee of our company in April 1999. None of Drs. Wang or Deng or our four other founders was subject to a noncompetition agreement with Synopsys at any time.
In February 2000, Synopsys filed a complaint in the Superior Court of the State of California in the County of Santa Clara (Case No. CV787950) against us and Dr. Deng, our President. The complaint alleged breach of contract, breach of fiduciary trust, diversion of corporate opportunity and constructive trust. In September 2001, Synopsys filed its second amended complaint, which added claims of inducing/aiding and abetting breach of fiduciary duty, including/aiding and abetting diversion of corporate opportunity, misappropriation of trade secrets, civil conspiracy, breach of confidence and unfair competition, and added as individual defendants Dr. Wang and our four other founders. In September 2002, Synopsys filed a supplemental second amended complaint that contained supplemental allegations but added no new claims or parties. In January 2003, the discovery referee issued orders creating rebuttable presumptions in favor of Synopsys on certain evidentiary issues to sanction us for erasure of certain computer files requested in discovery by Synopsys. These rulings mean that we must prove at trial that we did not take or use Synopsys source code or other confidential information, rather than the usual requirement that Synopsys provide such proof in the first instance. However, none of these rulings resolves any of the claims made by Synopsys in
10
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
the case and the trial judge or jury can reach their own conclusions based upon the evidence presented at trial. We filed a motion for reconsideration of this order and in March 2003, the Court denied our motion, concluding that it was barred on procedural grounds. In January 2003, Synopsys filed a third amended complaint, which contained supplemental allegations but added no new claims or parties. We have filed an answer denying Synopsys allegations. This action is currently in discovery. Synopsys has requested unspecified damages of at least $25 million, an injunction, a constructive trust on unspecified intellectual property belonging to us and other relief. A trial date has not yet been set.
We believe that we have meritorious defenses to Synopsys allegations and claims and we intend to continue to defend ourselves vigorously. However, because of the inherent uncertainty of litigation in general, and the fact that the discovery related to this litigation is ongoing, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we could be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. Although the final outcome of the litigation may not occur for some time, the parties periodically conduct evidence gathering, meet to discuss the status of the litigation and file motions and other requests for the court to act. The results of these periodic activities, particularly the courts decisions on current pending and future motions, could have the effect of determining the ultimate outcome of the litigation, either for or against us, prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. For example, in November 2001, the court denied a motion brought by Synopsys for injunctive relief that, if granted, could have prevented us from selling our products. If any of Synopsys motions ultimately prevail, our ability to defend ourselves against the claims brought against us in this litigation could be severely limited. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the Synopsys litigation. Accordingly, an adverse judgment, if entered in favor of any Synopsys claim, could seriously harm our business, financial position and results of operations can cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
In May 2001, Synopsys filed a complaint in the United States District Court, Northern District of California, San Jose division (Case No. CO1-20423 PVT) against us, alleging that our HSIM software infringes Synopsys U.S. Patent No. 5,878,053 entitled Hierarchical Power Network Simulation and Analysis tool for reliability testing of Deep Submicron IC Designs (the 053 patent). Since the case began, Synopsys has also alleged that our subsequently released HSIM 2.0 and LEXSIM products, infringe the 053 patent. Synopsys has requested relief including damages from $4.1 million to $13.7 million and an injunction. Synopsys has also requested that any damage award be trebled for alleged willful infringement. In June 2001, we filed an answer to the complaint denying infringement of a valid, enforceable patent and asserting counterclaims. We have since amended our counterclaims. Our current counterclaims allege that,
11
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
among other things, the 053 patent is invalid, unenforceable and not infringed and that Synopsys has violated federal antitrust and state unfair competition laws.
From time to time, the court has ruled on summary judgment motions in the case. In May 2002, the court granted summary judgment in favor of Synopsys on our invalidity defenses and counterclaims, concluding that they were barred by the doctrine of assignor estoppel. The court denied Synopsys motion with respect to our unenforceability defense and counterclaim. In November 2002, the court issued an order granting summary judgment in favor of Synopsys on certain antitrust counterclaims based on the doctrine of assignor estoppel. However, the court declined to rule on Synopsys motion with respect to our other antitrust and unfair competition counterclaims. In addition, the court issued a ruling construing the claims of the 053 patent in August 2002.
In September 2002, the U.S. Patent and Trademark Office granted our request for ex parte reexamination of the 053 patent based on prior art not previously considered by the Patent Office. We have moved to stay the federal litigation pending the outcome of the reexamination and the court granted our motion in December 2002. During the reexamination of the 053 patent, the Patent Office may determine that the subject matter in the patent is patentable as originally claimed, that the subject matter is patentable if the claims are modified or that the subject matter is not patentable. We cannot predict what the result of the reexamination procedure will be or how long it will take to complete.
Activity on several other summary judgment motions has been suspended because the court stayed the federal litigation. In November 2002, Synopsys filed three motions for summary judgment. The first motion asked the court to enter judgment before trial that Nassdas products infringe the 053 patent. The second motion asked the court to rule before trial against us on our defense that the 053 patent is unenforceable because Synopsys committed inequitable conduct in obtaining the patent. We submitted oppositions to both of these motions. Synopsys third motion asked the court to rule before trial against us on our remaining antitrust counterclaims. Because of the courts prior rulings against us on our other antitrust counterclaims, we did not oppose this motion. In November 2002, we also filed a summary judgment motion, which asked the court to enter judgment before trial that our products do not infringe the 053 patent. Synopsys opposed this motion. The Court issued its order staying the federal litigation before the parties reply briefs were due.
We believe we have meritorious defenses to Synopsys claims and intend to defend ourselves vigorously. However, because of the high degree of complexity of the intellectual property at issue, the inherent uncertainties of litigation in general and the preliminary nature of this litigation, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we may be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. The courts decisions on current pending and future motions could have the effect of determining the ultimate outcome of the litigation prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the
12
NASSDA CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)
(unaudited)
Synopsys litigation. Accordingly, an adverse judgment, if entered on any Synopsys claim, could seriously harm our business, financial position and results of operations and cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
Other Contingencies
In general, we provide our customers a 90-day limited warranty in connection with the licensing of our software that the software will perform substantially in accordance with our documentation. We do not maintain a general warranty reserve for estimated costs at the time revenue is recognized due to our extensive quality testing of the software. To date, we have incurred minimal costs related to this limited warranty obligation.
Our standard software license and maintenance agreements include an infringement indemnification provision for claims from third parties related to our intellectual property. The agreements generally limit the scope of the available remedies in a variety of industry-standard methods, including but not limited to a right to control the defense or settlement of any claim, procure the right for continued usage, and a right to replace or modify the infringing products to make them non-infringing. Such indemnification provisions are accounted for in accordance with SFAS No. 5. To date, we have not incurred any costs related to any claims under such indemnification provisions.
9. | Recent Accounting Pronouncements |
In October 2001, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, or SFAS No. 144, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Assets to Be Disposed of. We adopted SFAS No. 144 for fiscal 2003 beginning October 1, 2002. The adoption of SFAS No. 144 had no impact on our financial position, results of operations or cash flows.
In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based CompensationTransition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, SFAS No. 148 amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ending after December 15, 2002. We adopted the disclosure provisions of SFAS No. 148 for the quarterly period beginning on January 1, 2003. We do not expect to change to the fair value based method of accounting for stock-based employee compensation; therefore, the adoption of SFAS No. 148 is not expected to have an impact on our financial position, results of operation or cash flows.
13
MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q, including the sections titled Managements Discussion and Analysis of Financial Condition and Results of Operations and Litigation, contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industrys actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. In some cases you can identify forward-looking statements by terminology such as may, will, should, expects, plans, anticipates, believes, estimates, predicts, potential, continue or the negative of these terms or other comparable terminology. Forward looking statements include, but are not limited to: the statements under OverviewQuarterly Fluctuations regarding the impact of quarterly fluctuations of revenues on us; the statements under OverviewRevenue Recognition regarding the recognition of future revenue from the sale of our products; the statements in the second paragraph under Results of OperationsRevenues regarding international sales as a percentage of total revenue; the statements under Results of OperationsResearch and Development regarding the hiring of new personnel; the statement under Results of OperationsGeneral and Administrative regarding the increases in expenditure due to legal fees; the statements in the last paragraph under Liquidity and Capital Resources concerning the anticipated spending for capital additions for the remainder of fiscal 2003, the sufficiency of our available resources to meet cash requirements and the factors which will determine our future cash requirements; and the statements in Factors Affecting Future Operating Results. These statements are only predictions and you should not place undue reliance on these statements. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors including those discussed in Factors Affecting Future Operating Results below.
Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of these statements. We are under no duty to update any of the forward-looking statements after the date of this Quarterly Report on Form 10-Q to conform our prior statements to actual results, as a result of new information or otherwise.
Overview
We are a leading provider of full-chip circuit simulation and analysis software for the design and verification of complex nanometer-scale semiconductors. We believe that our initial product, HSIM, is the industrys first hierarchical simulator that meets the circuit verification challenges of todays integrated circuit designs, and we believe our second product, LEXSIM, is the leading electronic design automation tool able to simulate the nanometer effects of both the power network and signal interconnects for complex integrated circuits, or ICs, with millions of transistors. In December 2002, we also released our third product, CRITIC, which we believe is the first design automation tool able to automatically provide accurate analysis of nanometer effects on critical signal paths and clock networks for complex, high-performance digital ICs comprised of millions of gates and developed with customer-owned tooling flows. In April 2003, we released version 3.0 of HSIM with many new enhancements and a new digital co-simulation interface option. In May 2003, we also announced the limited customer release of our fourth product, HANEX, which we believe to be the first hybrid analysis tool to automatically identify critical paths, including the impact of crosstalk effects on signal timing for custom CMOS digital designs with millions of elements.
Our fiscal year ends on
14
September 30. Throughout this report we refer to the fiscal year ended September 30, 2002 as fiscal 2002, the fiscal year ending September 30, 2003 as fiscal 2003 and so on.
Sources of Revenue
We derive all of our revenue from software licensing and maintenance fees. To date, we have derived substantially all of this revenue from the licensing and support of HSIM. We do not expect LEXSIM, CRITIC or HANEX to account for any meaningful percentage of our total revenue until fiscal 2004. Our software does not require customization and generally does not require on-site implementation services. As a result, we have not generated any professional service or consulting revenue. We do not consider backlog to be a meaningful measure of future revenue because our customers can generally cancel orders without penalty.
Product RevenuePerpetual Licenses
Historically, we have generated the majority of our total revenue from perpetual licenses. Perpetual license customers pay a one-time license fee and are entitled to use the software as long as they desire. To receive support, periodic updates and new enhancements from us, perpetual license customers must purchase maintenance contracts.
Subscription RevenueTime-Based Licenses
Our time-based licenses give the customer the right to use our software for a fixed period of time, typically one to three years, and include maintenance. Time-based licenses can be renewed for one or more years. At times, customers may also require additional licenses for a shorter term, typically multiples of one-month licenses, to be used when they reach certain stages of the design process in conjunction with their other time-based or perpetual licenses. These shorter term licenses are sold primarily to help customers with their peak usage demands. To date, revenue from these shorter term licenses has not been significant. An increasing proportion of our total revenue is derived from time-based licenses, as more of our large customers who initially subscribe to time-based licenses renew those licenses or subscribe to additional time-based licenses. In todays challenging economic environment, other customers are also choosing to purchase time-based licenses due to their flexible licensing and payment terms and we expect this trend to continue.
Maintenance Revenue
Our perpetual license customers typically purchase maintenance contracts and renew them annually. Customers who purchase maintenance receive support, updates and enhancements when we make them available to our general installed base. We anticipate that as an increasing proportion of our future licenses come from time-based licenses, maintenance revenue may decrease as a percent of total revenue. Maintenance revenue may also fluctuate from quarter to quarter due to the timing of annual renewals.
Quarterly Fluctuations
Through the fiscal quarter ended December 31, 2002, we achieved 13 quarters of sequential revenue growth. However, our revenue for the fiscal quarter ended March 31, 2003 decreased by 14.9% as compared to the previous fiscal quarter. We believe the prolonged economic slowdown and seasonal factors in our business have caused and will continue to cause both the total revenue and each of the components to fluctuate from quarter to quarter. Our customers and prospective customers are controlling their spending even more in order to return to profitability, which causes extended sales cycles, smaller number of license
15
purchases or decreased or canceled budgets. Other seasonal factors include the mix between perpetual and time-based licenses, timing of the renewals of time-based licenses and maintenance, and payment terms, which may impact the timing of revenue recognition. Further, commissions represent a significant portion of our sales force compensation, which is structured to encourage sales closures prior to fiscal year end. As a result, we expect that sales efforts will intensify in the fourth fiscal quarter, which could result in our revenue being lower in the first quarter of the subsequent fiscal year.
Deferred Revenue
Time-based licenses and maintenance that are invoiced in advance and are either paid or due are included in deferred revenue and recognized ratably over the contract period on a straight-line basis. Deferred revenue also consists of deferred perpetual license fees for which all of the revenue recognition criteria have not been met. Deferred revenue fluctuates depending on the timing of perpetual licenses meeting all the revenue recognition criteria, as well as the number, subscription period, payment terms, and timing of renewals of time-based licenses and maintenance contracts.
Operating Expenses
Since our inception in August 1998, we have incurred substantial costs to develop our technology and products, recruit and train personnel for our engineering, sales and marketing and technical support departments and establish an administrative organization. We anticipate that our operating expenses will increase substantially in the future as we fund more research and development projects, increase our sales and marketing operations both domestically and internationally, develop new sales channels, broaden our technical support and improve our operational and financial systems. Our increased operating expenses will result primarily from higher headcount in all areas, and we expect our headcount to double over the next 18 to 24 months. In fiscal 2001 and fiscal 2002 and the six months ended March 31, 2003, legal fees and other expenses related to our litigation with Synopsys were $1.0 million, $5.6 million and $3.5 million, respectively. We also expect the cost of the Synopsys litigation to increase as we continue to defend ourselves vigorously and the lawsuits move toward trial. Additionally, we also expect costs related to being a public company, such as directors and officers liabilities insurance, professional fees and various filing fees to increase our general and administrative expenses. We believe that our operating expenses will grow in absolute dollars in future periods although the rate of growth in expenses from period to period may vary. We expect, however, that as a percent of revenue, operating expenses will fluctuate from quarter to quarter depending primarily upon the rate of growth in revenue. We will need to generate significant revenue in the future to maintain profitability.
To increase market share in international locations and better serve our customers, we plan to further expand our international operations selectively. As a result of these investments in our international operations, we may experience an increase in cost of sales and other operating expenses disproportionate to revenue from those operations.
In fiscal 2002, we accrued bonuses of an aggregate of $760,000 earned by our employees for their services in fiscal 2002. These bonuses will be paid over time on specified schedules. We paid $161,000 and $413,000 of these bonuses during the three and six months ended March 31, 2003, respectively. If an employee who provided services to us in fiscal 2002 is not employed by us on the scheduled date of a given bonus payment, we will pay the amounts due to that employee on December 15, 2006. In addition, our executive officers have orally agreed that they will not receive their base salaries in fiscal 2003. As a result of our significant bonus accruals in fiscal 2001 and fiscal 2002 and the foregone salaries in fiscal 2002 and fiscal
16
2003, our compensation expense in fiscal 2004 may not be consistent with that in fiscal 2001, fiscal 2002 or fiscal 2003.
Stock-Based Compensation
We recorded deferred stock-based compensation of $2.5 million in connection with stock option grants in fiscal 2001 and did not record any deferred stock-based compensation in fiscal 2002 or in the six months ended March 31, 2003. We have been amortizing this stock-based compensation over the vesting period of the related options, which is generally four years. We amortized $2.4 million and $1.0 million of stock-based compensation in fiscal 2001 and fiscal 2002, respectively. During the three and six months ended March 31, 2003, we recognized aggregate stock-based compensation expense of approximately $248,000 and $496,000, respectively. We expect aggregate stock-based compensation expense of approximately $496,000 during the remainder of fiscal 2003, approximately $908,000 during fiscal 2004 and approximately $307,000 during fiscal 2005.
Foreign Currency Transactions
Our revenue is generally denominated in United States dollars; however, our operating expenses in international locations are denominated in local currencies. Historically, our exposure to foreign exchange fluctuations has been minimal; however, as our international sales and operations expand, we anticipate that our exposure to risks associated with foreign currency fluctuations will increase.
Critical Accounting Policies
Revenue Recognition
We recognize revenue in accordance with the provisions of American Institute of Certified Public Accountants Statement of Position 97-2, Software Revenue Recognition, as amended by Statement of Position 98-4, Deferral of the Effective Date of Certain Provisions of SOP 97-2, and Statement of Position 98-9, Modification of SOP 97-2, Software Revenue Recognition with Respect to Certain Transactions.
We recognize and report revenue in three separate categories: product revenue, subscription revenue and maintenance revenue. Product revenue is derived from perpetual license fees. Subscription revenue is derived from time-based license fees and includes maintenance during the license period. We recognize product revenue and subscription revenue when all of the following conditions are met:
| a written purchase order, license agreement or other contract has been executed; |
| the product and the production license key have been delivered; |
| user acceptance periods, if any, have expired; |
| the license fee is fixed and determinable; and |
| collection of the fee is probable. |
Vendor specific objective evidence exists for maintenance on perpetual licenses based on renewal rates. Our customers generally purchase the first year of maintenance when they purchase a perpetual license, so we use the residual method to determine the allocation of revenue to the license portion of multiple element arrangements involving perpetual licenses. Because we bundle both the license and maintenance into
17
our agreements for time-based licenses for the entire term, vendor specific objective evidence does not exist for each element of the arrangement. Therefore, we recognize subscription revenue from time-based licenses ratably over the period of the license. Maintenance revenue is derived from the annual maintenance contracts that are purchased by perpetual licensees. We generally recognize revenue from maintenance ratably over the maintenance period, which is typically one year.
Future changes in accounting pronouncements, including those affecting revenue recognition, could require us to change our methods of revenue recognition. These changes could cause us to defer revenue from current periods to subsequent periods or accelerate recognition of deferred revenue to current periods.
Allowance for Doubtful Accounts
We maintain an allowance for doubtful accounts based on managements best estimate of probable losses inherent in the outstanding accounts receivable balance. Management determines the allowance based on known troubled accounts, historical experience and other currently available evidence. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.
Sales Commission Accrual and Expenses
Sales commissions are earned and paid to our sales force for each order received, shipped and collected. Based on our policies, we pay a portion of the sales commissions based on both bookings and collections and the commission rate varies depending on each sales persons ability to attain his or her annual quota. Commission rates increase as the sales person achieves a certain percentage of his or her annual quota. We determine an estimated average annual commission rate during the first three fiscal quarters for purposes of accruing commissions. We adjust the balance of the commissions accrual and the actual commission expense at the end of each fiscal year based on each sales persons actual commission rates.
18
Results of Operations
The following table sets forth the results of our operations expressed as a percent of total revenue. Our historical operating results are not necessarily indicative of the results for any future period.
Three Months Ended March 31, |
Six Months Ended March 31, |
|||||||||||
2003 |
2002 |
2003 |
2002 |
|||||||||
Revenue: |
||||||||||||
Product |
36.5 |
% |
55.0 |
% |
41.0 |
% |
59.0 |
% | ||||
Subscription |
39.1 |
|
30.5 |
|
37.6 |
|
26.7 |
| ||||
Maintenance |
24.4 |
|
14.5 |
|
21.4 |
|
14.3 |
| ||||
Total revenue |
100.0 |
|
100.0 |
|
100.0 |
|
100.0 |
| ||||
Cost of revenue: |
||||||||||||
Product |
0.7 |
|
0.7 |
|
0.7 |
|
0.9 |
| ||||
Subscription |
1.0 |
|
0.8 |
|
0.9 |
|
0.8 |
| ||||
Maintenance |
2.2 |
|
2.0 |
|
2.1 |
|
2.1 |
| ||||
Gross profit |
96.1 |
|
96.5 |
|
96.3 |
|
96.2 |
| ||||
Operating expenses: |
||||||||||||
Research and development |
19.4 |
|
15.9 |
|
16.9 |
|
17.1 |
| ||||
Sales and marketing |
32.7 |
|
28.6 |
|
30.0 |
|
29.2 |
| ||||
General and administrative |
27.4 |
|
23.1 |
|
25.5 |
|
23.3 |
| ||||
Stock-based compensation |
2.8 |
|
3.1 |
|
2.6 |
|
3.3 |
| ||||
Total operating expenses |
82.3 |
|
70.7 |
|
75.0 |
|
72.9 |
| ||||
Income from operations |
13.8 |
|
25.8 |
|
21.3 |
|
23.3 |
| ||||
Interest income |
2.9 |
|
2.7 |
|
2.7 |
|
2.2 |
| ||||
Other income (expense), net |
(0.1 |
) |
|
|
(0.1 |
) |
|
| ||||
Income before taxes |
16.6 |
|
28.5 |
|
23.9 |
|
25.5 |
| ||||
Provision for taxes |
(5.0 |
) |
(11.1 |
) |
(8.0 |
) |
(9.5 |
) | ||||
Net income |
11.6 |
% |
17.4 |
% |
15.9 |
% |
16.0 |
% | ||||
Three and Six Months Ended March 31, 2003
Revenue
Total Revenue. Our revenue consists of product, subscription and maintenance revenue. Total revenue increased by 9.7%, or $778,000, to $8.8 million in the three months ended March 31, 2003 from $8.0 million for the three months ended March 31, 2002, and increased by 26.6%, or $4.0 million, to $19.1 million for the six months ended March 31, 2003 from $15.1 million for the six months ended March 31, 2002. The increases were attributable to an increase in our end user base, resulting in substantial growth in subscription and maintenance revenue, partially offset by decreases in additional perpetual license sales.
Revenue from sales outside of North America accounted for 37.9% and 42.7% of total revenue for the three months ended March 31, 2003 and 2002, respectively, and 38.8% and 45.7% of total revenue for the six months ended March 31, 2003 and 2002, respectively. The percent of total revenue from outside of North America decreased due to domestic revenue growing at a faster rate than revenue from outside of North America as we penetrated into more domestic major accounts. Revenue from Japan was 14.8% and 18.6% of our total revenue in the three months ended March 31, 2003 and 2002, respectively, and 14.5% and 24.7% of total revenue for the six months ended March 31, 2003 and 2002, respectively. No other country outside North America accounted for more than 10% of our total revenue in any of these periods. We expect that revenue from sales outside of North America will continue to account for a significant portion of our total revenue in the future.
19
Marubeni Solutions, our exclusive distributor for Japan, accounted for approximately 14.8% and 18.6% of our total revenue for the three months ended March 31, 2003 and 2002, respectively, and 14.5% and 24.7% of total revenue for the six months ended March 31, 2003 and 2002, respectively. Broadcom Corporation accounted for approximately 12.9% of our total revenue for the six months ended March 31, 2003 and 11.5% of our total revenue for the three months ended March 31, 2002, respectively. No other direct customer or distributor accounted for more than 10% of our total revenue during any of these periods.
Deferred revenue includes perpetual license fees for which all of the revenue recognition criteria had not been met, time-based license fees that have been invoiced and due for which we recognize revenue ratably over the term of the license period, and maintenance fees on perpetual licenses for which we also recognized revenue ratably over the term of the maintenance period. Our deferred revenue increased to $7.5 million as of March 31, 2003 from $6.1 million as of September 30, 2002, but decreased slightly from $7.8 million as of December 31, 2002. We expect deferred revenue to fluctuate from quarter to quarter due to the number of additional time-based license purchases, the timing of renewals of time-based licenses and maintenance and their respective payment terms. Additionally, deferred revenue may not increase if more customers prefer quarterly payments for time-based licenses and maintenance.
Product Revenue. Product revenue decreased by 27.2%, or $1.2 million, to $3.2 million for the three months ended March 31, 2003 from $4.4 million for the three months ended March 31, 2002, and decreased by 12.1%, or $1.1 million, to $7.8 million for the six months ended March 31, 2003 from $8.9 million for the six months ended March 31, 2002. These decreases were primarily due to more customers, particularly major accounts, purchasing time-based licenses as compared to perpetual licenses. As a percent of total revenue, product revenue decreased to 36.5% for the three months ended March 31, 2003 from 55.0% for the three months ended March 31, 2002, and decreased to 41.0% for the six months ended March 31, 2003 from 59.0% for the six months ended March 31, 2002, as the sales of perpetual licenses was outpaced by growth in the sales of time-based licenses.
Subscription Revenue. Subscription revenue increased by 40.5%, or $993,000, to $3.4 million for the three months ended March 31, 2003 from $2.5 million for the three months ended March 31, 2002, and increased by 78.0%, or $3.2 million, to $7.2 million for the six months ended March 31, 2003 from $4.0 million for the six months ended March 31, 2002. The increases were primarily due to new customers purchasing time-based licenses, as well as existing customers purchasing additional time-based licenses and renewing their expired time-based licenses. As a percent of total revenue, subscription revenue rose to 39.1% for the three months ended March 31, 2003 from 30.5% for the three months ended March 31, 2002, and rose to 37.6% for the six months ended March 31, 2003 from 26.7% for the six months ended March 31, 2002. We expect time-based licenses to account for an increasing proportion of total revenue in the future.
Maintenance Revenue. Maintenance revenue increased by 84.4%, or $982,000, to $2.1 million for the three months ended March 31, 2003 from $1.2 million for the three months ended March 31, 2002, and increased by 90.5%, or $1.9 million, to $4.1 million for the six months ended March 31, 2003 from $2.2 million for the six months ended March 31, 2002. The increases in maintenance revenue were due to the increase in the number of perpetual licenses in the installed base. As a percent of total revenue, maintenance revenue increased to 24.4% for the three months ended March 31, 2003 from 14.5% for the three months ended March 31, 2002, and increased to 21.4% for the six months ended March 31, 2003 from 14.2% for the six months ended March 31, 2002. We expect maintenance revenue to vary as a percent of total revenue based on the growth rate of product revenue relative to subscription revenue and the number of customers renewing annual maintenance. If maintenance revenue increases as a percent of total revenue, our gross profit
20
as a percent of total revenue, or gross margin, may decrease because of lower margins on maintenance revenue than product revenue due to incremental maintenance support costs.
Cost of Revenue
Cost of Product Revenue. Cost of product revenue consists primarily of royalties due from us to third parties under original equipment manufacturer arrangements. We incur only minimal costs to deliver our software as the product and documentation are primarily sent electronically. Our cost of product revenue increased by 14.7%, or $8,000, to $63,000 for the three months ended March 31, 2003 from $55,000 for the three months ended March 31, 2002, but decreased by 4.3%, or $6,000, to $129,000 for the six months ended March 31, 2003 from $135,000 for the six months ended March 31, 2002, due to decrease in the sublicensing of third-party products. As a percent of total revenue, the cost of product revenue remained constant at 0.7% for the three months ended March 31, 2003 and 2002, and decreased to 0.7% for the six months ended March 31, 2003 from 0.9% for the six months ended March 31, 2002. We expect the cost of product revenue as a percent of total revenue to continue to vary based on the sales of third-party products.
Cost of Subscription Revenue. Cost of subscription revenue consists primarily of personnel and allocated overhead expenses for support of time-based licenses. Our cost of subscription revenue increased by 25.2%, or $17,000, to $84,000 for the three months ended March 31, 2003 from $67,000 for the three months ended March 31, 2002, and increased by 44.1% or $52,000, to $170,000 for the six months ended March 31, 2003 from $117,000 for the six month ended March 31, 2002. The increases in cost of subscription revenue were primarily due to the increase in personnel and other costs associated with the support of a larger number of time-based licenses. As a percent of total revenue, the cost of subscription revenue increased to 1.0% for the three months ended March 31, 2003 from 0.8% for the three months ended March 31, 2002, and increased to 0.9% for the six months ended March 31, 2003 from 0.8% for the six months ended March 31, 2002. We expect the absolute dollar amount of the cost of subscription revenue to increase over the next 12 months.
Cost of Maintenance Revenue. Cost of maintenance revenue consists primarily of personnel and other expenses related to providing maintenance support to our customers who purchase perpetual licenses. Our cost of maintenance revenue increased by 25.9%, or $41,000, to $197,000 for the three months ended March 31, 2003 from $156,000 for the three months ended March 31, 2002, and increased by 27.2%, or $85,000, to $398,000 for the six months ended March 31, 2003 from $313,000 for the six months ended March 31, 2002. The increases in cost of maintenance revenue were primarily due to increased hiring of dedicated support personnel to provide support to a growing installed user base. As a percent of total revenue, the cost of maintenance revenue increased to 2.2% for the three months ended March 31, 2003 from 2.0% for the three months ended March 31, 2002, and remained constant at 2.1% for the six months ended March 31, 2003 and 2002. The increase in the cost of maintenance revenue as a percent of total revenue was primarily due to the additional resources required in supporting an increasing number of perpetual licensees. We expect that the absolute dollar amount of cost of maintenance revenue will grow in the next 12 months as we continue to increase support for our growing base of domestic and international customers.
Operating Expenses
Research and Development. Research and development expenses consist of engineering costs to develop new products, enhance existing products and perform quality assurance activities. Our research and development expenses increased by 33.9%, or $432,000, to $1.7 million for the three months ended March 31, 2003 from $1.3 million for the three months ended March 31, 2002, and increased by 25.1%, or
21
$650,000, to $3.2 million for the six months ended March 31, 2003 from $2.6 million for the six months ended March 31, 2002. The increases in research and development expenses were primarily due to the hiring of additional research and development personnel, partially offset by decreases in bonuses. Research and development headcount increased to 43 at March 31, 2003 from 32 at March 31, 2002. As a percent of total revenue, research and development expenses increased to 19.4% in the three months ended March 31, 2003 from 15.9% in the three months ended March 31, 2002, but decreased to 16.9% in the six months ended March 31, 2003 from 17.1% in the six months ended March 31, 2002. We anticipate that research and development expenses will continue to increase in absolute dollars in the future.
Sales and Marketing. Sales and marketing expenses consist primarily of salaries, commissions, travel, promotional and advertising costs. Our sales and marketing expenses increased by 25.3%, or $581,000, to $2.9 million for the three months ended March 31, 2003 from $2.3 million for the three months ended March 31, 2002, and increased by 30.4%, or $1.3 million, to $5.7 million for the six months ended March 31, 2003 from $4.4 million for the six months ended March 31, 2002. The absolute dollar increases in sales and marketing expenses were primarily due to the hiring of additional sales, application engineering, and marketing personnel, which increased to 51 at March 31, 2003 from 38 at March 31, 2002, and, to a lesser extent, increased travel, trade show and other marketing activities and the expansion of our sales offices. As a percent of total revenue, sales and marketing expenses increased to 32.7% in the three months ended March 31, 2003 from 28.6% in the three months ended March 31, 2002, and increased to 30.0% in the six months ended March 31, 2003 from 29.2% in the six months ended March 31, 2002. We expect that sales and marketing expenses will continue to increase in absolute dollars in future periods as we further expand our global sales and support organization.
General and Administrative. General and administrative expenses represent corporate, finance, human resource, administrative, legal and consulting expenses. Our general and administrative expenses increased by 30.0%, or $557,000, to $2.4 million for the three months ended March 31, 2003 from $1.9 million for the three months ended March 31, 2002, and increased by 38.5%, or $1.4 million, to $4.9 million for the six months ended March 31, 2003 from $3.5 million for the six months ended March 31, 2002. As a percent of total revenue, general and administrative expenses increased to 27.4% for the three months ended March 31, 2003 from 23.1% for the three months ended March 31, 2002, and increased to 25.5% for the six months ended March 31, 2003 from 23.3% for the six months ended March 31, 2002. The increases in general and administrative expenses were primarily due to legal fees, cost of public company compliance reporting and liability insurance. General and administrative headcount increased to 12 at March 31, 2003 from 10 at March 31, 2002. We expect that general and administrative expenses will continue to increase in absolute dollars to support the growth of our future operations, as well as from increased legal fees, liability insurance and the costs of public company compliance reporting.
Stock-Based Compensation. Stock-based compensation expense decreased by 1.6%, or $4,000, to $248,000 for the three months ended March 31, 2003 from $252,000 for the three months ended March 31, 2002, and decreased by 1.6%, or $8,000, to $496,000 for the six months ended March 31, 2003 from $504,000 for the six months ended March 31, 2002. As a percent of total revenue, stock-based compensation expense decreased to 2.8% for the three months ended March 31, 2003 from 3.1% for the three months ended March 31, 2002, and decreased to 2.6% for the six months ended March 31, 2003 from 3.3% for the six months ended March 31, 2002 due to increases in revenue.
22
Interest Income
Interest income increased by 18.5%, or $40,000, to $256,000 for the three months ended March 31, 2003 from $216,000 for the three months ended March 31, 2002, and increased by 56.4%, or $189,000, to $524,000 for the six months ended March 31, 2003 from $335,000 for the six months ended March 31, 2002. Due to net proceeds from our initial public offering and increasing profitability and cash flow, cash balances increased, which resulted in increased interest income, despite lower interest rates. As a percent of total revenue, interest income increased to 2.9% for the three months ended March 31, 2003 from 2.7% for the three months ended March 31, 2002, and increased to 2.7% for the six months ended March 31, 2003 from 2.2% for the six months ended March 31, 2002.
Other Income (Expense), Net
Our other income (expense), net increased to a net expense of $10,000 for the three months ended March 31, 2003 as compared to a net expense of $2,000 for the three months ended March 31, 2002 and a net expense of $30,000 for the six months ended March 31, 2003 as compared to a net expense of $5,000 for the six months ended March 31, 2002. The increase was primarily due to foreign exchange losses as a result of a weaker United States dollar as compared to foreign currencies in which we pay a portion of our expenses.
Income Taxes
The provision for income taxes as a percent of income before taxes was 30.0% and 33.4% for the three months and six months ended March 31, 2003, respectively, as compared to 39.0% and 37.4% for the same periods in the prior year, respectively. The decrease in the effective tax rate from the prior year was primarily due to increased permanent tax differences, as pre-tax income for fiscal 2003 is expected to be lower than fiscal 2002. In addition, we have experienced more tax benefits during fiscal 2003 as compared to fiscal 2002 related to exercises of stock options for which stock-based compensation has been recorded.
Liquidity and Capital Resources
Since inception, we have financed our operations primarily through private sales of preferred stock for aggregate proceeds of $525,000 in September 1998 and $1.5 million in May 1999. We have also financed our operations through the sale of common stock to employees and cash generated from profits. In December 2001 and January 2002, we sold 5,750,000 shares of common stock in connection with our initial public offering at $11.00 per share. Total net proceeds after deducting underwriting discounts and offering expenses were approximately $57.2 million.
As of March 31, 2003, we had cash, cash equivalents and short-term investments of $85.0 million and working capital of $77.9 million.
Net cash provided by operating activities was $5.6 million for the six months ended March 31, 2003 and $2.3 million for the six months ended March 31, 2002. Net cash provided by operating activities for the six months ended March 31, 2003 resulted primarily from net income, increases in deferred revenue and accrued liabilities and a decrease in accounts receivable, partially offset by increases in prepaid expenses and other current assets and a decrease in accounts payable. Net cash provided by operating activities for the six months ended March 31, 2002 resulted primarily from net income and increases in accounts payable and accrued liabilities, offset by decreases in deferred revenue, long term liabilities and increases in accounts receivable.
23
Net cash used in investing activities was $2.7 million for the six months ended March 31, 2003 and $4.9 million for the six months ended March 31, 2002. In both periods, the net cash used primarily related to the purchase of investment securities with maturities of 91 days to one year and purchases of property and equipment.
Net cash provided by financing activities was $1.3 million for the six months ended March 31, 2003 and $57.0 million for the six months ended March 31, 2002. For the six months ended March 31, 2003, net cash provided by financing activities was from proceeds generated by stock option exercises and the employees stock purchase plan. For the six months ended March 31, 2002, net cash provided by financing activities was primarily from the net proceeds from the sale of five million shares of common stock in our December 2001 initial public offering and an additional 750,000 shares in January 2002 pursuant to the exercise of the over-allotment option by our underwriters.
Capital expenditures were approximately $382,000 for the six months ended March 31, 2003 and $161,000 for the six months ended March 31, 2002. Our capital expenditures consisted of purchases of computer equipment, software and office furniture and fixtures. We expect to invest approximately $1.0 million during the remainder of fiscal 2003 for similar assets.
As of March 31, 2003, we had no borrowings, lines of credit, outstanding equipment leases or lease lines.
We intend to continue to invest heavily in the development of new products and enhancements to existing products. We also intend to increase our sales and marketing operations. Our future liquidity and capital requirements will depend on numerous factors, including:
| the amount and timing of orders and their respective payment terms; |
| the extent to which our existing and new products gain market acceptance; |
| the extent to which customers continue to renew annual time-based licenses and maintenance; |
| the cost and timing of expansion of product research and development efforts, including such efforts outside North America, and the success of these development efforts; |
| the cost and timing of expansion of sales and marketing activities, including such activities outside North America; |
| the cost of legal fees related to the defense of the claims filed against us by Synopsys; and |
| available borrowings under future credit arrangements, if any. |
We believe that our current cash and investment balances and any cash generated from operations, will be sufficient to meet our operating and capital requirements for at least the next 18 months. However, it is possible that we may require additional financing within this period. We have no current plans, and we are not currently negotiating to obtain additional financing. The factors described above will affect our future capital requirements and the adequacy of our available funds. In addition, even if we raise sufficient funds to meet our anticipated cash needs during the next 18 months, we may need to raise additional funds beyond this time. We may be required to raise those funds through public or private financings, strategic relationships or other arrangements. We cannot assure you that such funding, if needed, will be available on terms attractive to us, or at all. Furthermore, any additional equity financing may be dilutive to stockholders, and debt
24
financing, if available, may involve restrictive covenants. If we fail to raise capital as and when needed, our failure could have a negative impact on our ability to pursue our business strategy and maintain profitability.
Lease Commitments
We lease our facilities under various noncancelable operating leases, which expired beginning in February 2003. Rent expense was $365,000 in fiscal 2001 and $600,000 in fiscal 2002. As of September 30, 2002, the aggregate future noncancelable minimum rentals or operating leases are as follows (in thousands):
Year Ending September 30, |
|||
2003 |
$ |
417 | |
2004 |
|
16 | |
2005 |
|
2 | |
$ |
435 | ||
In December 2002, we entered into a three-year operating lease, which began in February 2003. The lease is for our primary business operation. The future minimum lease obligations related to this lease are $982,000.
Recent Accounting Pronouncements
In October 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Assets to Be Disposed of. We adopted SFAS No. 144 for fiscal 2003 beginning October 1, 2002. The adoption of SFAS No. 144 had no impact on our financial position, results of operations or cash flows.
In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based CompensationTransition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. In addition, SFAS No. 148 amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ending after December 15, 2002. We intend to adopt the disclosure provisions of SFAS No. 148 for the quarterly period beginning on January 1, 2003. We do not expect to change to the fair value based method of accounting for stock-based employee compensation; therefore, the adoption of SFAS No. 148 is not expected to have an impact on our financial position, results of operation or cash flows.
Non-Audit Services of Independent Auditors
Our auditors, Deloitte & Touche LLP, perform the following non-audit services that have been approved by our Audit Committee of the Board of Directors during the three months ended March 31, 2003: statutory compliance and tax related services for our foreign subsidiaries (other than tax-related services, which have previously been approved) and consultations with respect to generally accepted accounting principles.
25
Factors Affecting Future Results
We have relied and expect to continue to rely on HSIM for a substantial majority of our revenue, and a decline in sales of licenses for HSIM could cause our revenue to decline.
Historically, we have derived substantially all of our revenue from HSIM. We believe HSIM is the first hierarchical simulator that meets the circuit verification challenges of complex nanometer semiconductors. We expect that the revenue from this product will continue to account for substantially all of our revenue for at least the next 12 months. The electronic design automation software market, including the market for hierarchical simulator software, is characterized by rapid technological change, frequent new product introductions, uncertain product life cycles and evolving industry standards. If our competitors introduce new products and/or offer aggressive pricing that compete with HSIM, our revenue could decline materially and our results of operations could be harmed. For instance, in the three months ended March 31, 2003, certain competitors were offering extremely competitive prices which resulted in a longer sales cycle for HSIM or delays by prospective customers in making their purchasing decisions. Since we expect HSIM to continue to account for substantially all of our revenue in fiscal 2003, any factors adversely affecting the pricing of our licenses of or demand for HSIM, including competition or technological change, could cause our revenue to decline materially and our business to suffer. Some of the factors that may affect sales of HSIM may be beyond our control.
Our revenue would decline substantially if our existing customers do not purchase additional licenses or renew existing time-based licenses and maintenance from us.
We rely on additional perpetual and time-based license revenue from our existing customers, as well as annual maintenance renewals for our perpetual licenses and renewal of our time-based licenses when they expire. Even if we are successful in generating revenue from our software to new customers, if our existing customers do not purchase additional licenses for our software or renew their annual maintenance for perpetual licenses, we would experience a decline in revenue. For instance, even though some of our existing customers purchased additional licenses during the three months ended March 31, 2003, the number of licenses purchased and the average sales prices were lower than expected, which negatively impacted our revenue for the fiscal quarter. We would also experience a material decline in revenue if customers with time-based licenses do not renew those licenses when they expire.
If semiconductor design and manufacturing companies continue to experience recession or other conditions which impact their operating budgets, they may delay or cancel purchases of our software, which would reduce our revenues and cause our business to suffer.
The primary customers for our software are semiconductor design and manufacturing companies. Any significant downturn in our customers markets, or domestic and global conditions, which result in the reduction of research and development budgets or the delay of software purchases, would likely result in a decline in demand for our software and services and could harm our business. Since early 2000, the semiconductor industry has experienced a substantial decline in order volume and revenue and that downturn has continued. In addition, the war between the United States and Iraq may negatively impact the economy in general and in particular, may negatively affect the semiconductor design and manufacturing industry. This could result in our customers delaying or canceling the purchase of our software. Any of these occurrences could have a significant impact on our operating results, revenues and costs and may cause the market price of our common stock to decline or become more volatile. For example, we experienced a substantial change in customers behavior during the three months ended March 31, 2003 due to the prolonged economic downturn
26
and concerns for their own financial stability. Consequently, as a cost-cutting measure, customers either suspended or reduced their capital budgets dramatically, which adversely affected our revenue for the fiscal quarter.
In addition, the markets for semiconductor products are cyclical. For example, in recent years certain Asian countries have experienced significant economic difficulties, including currency devaluation and instability, business failures and a depressed business environment. More recently, certain Asian countries have also experienced difficulties from the effect of SARS. These difficulties have triggered a significant downturn in the semiconductor market, resulting in reduced budgets for chip design tools, which, in turn, has negatively impacted us. We cannot predict what impact the recent economic slowdown and in particular, the semiconductor industry, will have on our business, but it may result in fewer purchases of licenses of our software, substitution to our lower priced configurations by customers who previously licensed our higher priced configurations or nonrenewal of time-based licenses. If the current economic slowdown continues, we may not meet our revenue expectations for upcoming quarters.
We are currently a defendant in two lawsuits brought by Synopsys. The prosecution of these lawsuits could have a substantial negative impact on our business. Should Synopsys prevail, we may be required to pay substantial monetary damages or be prevented from selling our software.
Synopsys has filed claims against us in state and federal court. These claims are based on the alleged facts and circumstances relating to the departure of our five founders from their employment at Synopsys, the founding of our company and the development and sale of HSIM and our other products. Each of our founders and Dr. Sang S. Wang, our Chief Executive Officer, became an employee of Synopsys when Synopsys acquired EPIC Design Technology in February 1997. Dr. Wang resigned from Synopsys in March 1998 and served as a consultant to Synopsys until June 1998. Dr. An-Chang Deng, our President, and our four other founders resigned from Synopsys at approximately the same time in August 1998 and became employees of our company immediately thereafter. Dr. Wang became an employee of our company in April 1999. None of Drs. Wang or Deng or our four other founders was subject to a noncompetition agreement with Synopsys at any time.
In February 2000, Synopsys filed a complaint in the Superior Court of the State of California in the County of Santa Clara (Case No. CV787950) against us and Dr. Deng, our President. The complaint alleged breach of contract, breach of fiduciary trust, diversion of corporate opportunity and constructive trust. In September 2001, Synopsys filed its second amended complaint, which added claims of inducing/aiding and abetting breach of fiduciary duty, including/aiding and abetting diversion of corporate opportunity, misappropriation of trade secrets, civil conspiracy, breach of confidence and unfair competition, and added as individual defendants Dr. Wang and our four other founders. In September 2002, Synopsys filed a supplemental second amended complaint that contained supplemental allegations but added no new claims or parties. In January 2003, the discovery referee issued orders creating rebuttable presumptions in favor of Synopsys on certain evidentiary issues to sanction us for erasure of certain computer files requested in discovery by Synopsys. These rulings mean that we must prove at trial that we did not take or use Synopsys source code or other confidential information, rather than the usual requirement that Synopsys provide such proof in the first instance. However, none of these rulings resolves any of the claims made by Synopsys in the case and the trial judge or jury can reach their own conclusions based upon the evidence presented at trial. We filed a motion for reconsideration of this order and in March 2003, the Court denied our motion, concluding that it was barred on procedural grounds. In January 2003, Synopsys filed a third amended complaint, which contained supplemental allegations but added no new claims or parties. We have filed an answer denying Synopsys allegations. This action is currently in discovery. Synopsys has requested
27
unspecified damages of at least $25 million, an injunction, a constructive trust on unspecified intellectual property belonging to us and other relief. A trial date has not yet been set.
We believe that we have meritorious defenses to Synopsys allegations and claims and we intend to continue to defend ourselves vigorously. However, because of the inherent uncertainty of litigation in general, and the fact that the discovery related to this litigation is ongoing, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we could be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. Although the final outcome of the litigation may not occur for some time, the parties periodically conduct evidence gathering, meet to discuss the status of the litigation and file motions and other requests for the court to act. The results of these periodic activities, particularly the courts decisions on current pending and future motions, could have the effect of determining the ultimate outcome of the litigation, either for or against us, prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. For example, in November 2001, the court denied a motion brought by Synopsys for injunctive relief that, if granted, could have prevented us from selling our products. If any of Synopsys motions ultimately prevail, our ability to defend ourselves against the claims brought against us in this litigation could be severely limited. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the Synopsys litigation. Accordingly, an adverse judgment, if entered in favor of any Synopsys claim, could seriously harm our business, financial position and results of operations can cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
In May 2001, Synopsys filed a complaint in the United States District Court, Northern District of California, San Jose division (Case No. CO1-20423 PVT) against us, alleging that our HSIM software infringes Synopsys U.S. Patent No. 5,878,053 entitled Hierarchical Power Network Simulation and Analysis tool for reliability testing of Deep Submicron IC Designs (the 053 patent). Since the case began, Synopsys has also alleged that our subsequently released HSIM 2.0 and LEXSIM products, infringe the 053 patent. Synopsys has requested relief including damages from $4.1 million to $13.7 million and an injunction. Synopsys has also requested that any damage award be trebled for alleged willful infringement. In June 2001, we filed an answer to the complaint denying infringement of a valid, enforceable patent and asserting counterclaims. We have since amended our counterclaims. Our current counterclaims allege that, among other things, the 053 patent is invalid, unenforceable and not infringed and that Synopsys has violated federal antitrust and state unfair competition laws.
From time to time, the court has ruled on summary judgment motions in the case. In May 2002, the court granted summary judgment in favor of Synopsys on our invalidity defenses and counterclaims, concluding that they were barred by the doctrine of assignor estoppel. The court denied Synopsys motion with respect to our unenforceability defense and counterclaim. In November 2002, the court issued an order granting summary judgment in favor of Synopsys on certain antitrust counterclaims based on the doctrine of assignor estoppel. However, the court declined to rule on Synopsys motion with respect to our other antitrust
28
and unfair competition counterclaims. In addition, the court issued a ruling construing the claims of the 053 patent in August 2002.
In September 2002, the U.S. Patent and Trademark Office granted our request for ex parte reexamination of the 053 patent based on prior art not previously considered by the Patent Office. We have moved to stay the federal litigation pending the outcome of the reexamination and the court granted our motion in December 2002. During the reexamination of the 053 patent, the Patent Office may determine that the subject matter in the patent is patentable as originally claimed, that the subject matter is patentable if the claims are modified or that the subject matter is not patentable. We cannot predict what the result of the reexamination procedure will be or how long it will take to complete.
Activity on several other summary judgment motions has been suspended because the court stayed the federal litigation. In November 2002, Synopsys filed three motions for summary judgment. The first motion asked the court to enter judgment before trial that Nassdas products infringe the 053 patent. The second motion asked the court to rule before trial against us on our defense that the 053 patent is unenforceable because Synopsys committed inequitable conduct in obtaining the patent. We submitted oppositions to both of these motions. Synopsys third motion asked the court to rule before trial against us on our remaining antitrust counterclaims. Because of the courts prior rulings against us on our other antitrust counterclaims, we did not oppose this motion. In November 2002, we also filed a summary judgment motion, which asked the court to enter judgment before trial that our products do not infringe the 053 patent. Synopsys opposed this motion. The Court issued its order staying the federal litigation before the parties reply briefs were due.
We believe we have meritorious defenses to Synopsys claims and intend to defend ourselves vigorously. However, because of the high degree of complexity of the intellectual property at issue, the inherent uncertainties of litigation in general and the preliminary nature of this litigation, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we may be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. The courts decisions on current pending and future motions could have the effect of determining the ultimate outcome of the litigation prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the Synopsys litigation. Accordingly, an adverse judgment, if entered on any Synopsys claim, could seriously harm our business, financial position and results of operations and cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
Because many of our current competitors have greater resources than we do and pre-existing relationships with our potential customers, we might not be able to achieve sufficient market penetration to sustain profitability or gain additional market share.
We face significant competition from larger companies that market suites of electronic design automation products that address all or almost all steps in the semiconductor design process. Many of these
29
competitors have substantially greater financial, customer support, technical and marketing resources, larger customer bases, longer operating histories, greater name recognition and more established relationships in the industry than we do. In addition, other electronic design automation companies have recently announced that they intend to introduce new hierarchical simulation products with competing capabilities to ours. We cannot be sure that we will have the resources or expertise to compete successfully in the future. If we are unable to gain additional market share due to their pre-existing relationships with our potential customers, our operating results will be negatively impacted.
Our software is used to simulate and analyze complex nanometer-scale semiconductor designs. Our competitors in the electronics design automation industry who offer products that are used for other segments of the semiconductor design process often bundle their products together to offer discounts on products competitive with those we offer, making those products extremely attractive for our customers or potential customers to use. In addition, these competitors may not support our effort to integrate our software into their existing software. These competitors include such companies as Cadence Design Systems, Inc., Mentor Graphics Corporation and Synopsys. Since these competitors offer a more comprehensive range of products than we do, they are often able to respond more quickly or price more effectively to take advantage of new or changing opportunities and respond to new technologies and customer requirements. We cannot assure you that we will be able to compete successfully in such environments. If we lose such opportunities to our competitors, our results of operations could be harmed significantly.
Our business depends on continued demand for complex nanometer-scale semiconductors and the electronic equipment that incorporate them.
Our software is used to design complex nanometer-scale semiconductors that are an integral part of portable consumer electronics, networking equipment, wireless communications equipment, multimedia devices and personal computers. As a result, if the demand for these devices and businesses of the manufacturers of these products do not continue to grow, our revenue and business will suffer. Demand for portable consumer electronics may decrease if mobile phone, electronic mail or Internet use declines, the cost of those services increases or consumers fail to adopt latest generation portable electronics. Potential consumers of portable consumer electronics may use or modify existing equipment and never adopt next generation portable consumer electronics. Demand for other complex electronic equipment, such as networking equipment, may decrease if service providers do not experience subscriber growth or defer network build outs or other capital spending.
Purchases of licenses of our software are largely dependent upon the commencement of new design projects by semiconductor manufacturers and their customers, the number of design engineers and the increasing complexity of designs. Since late 2000, the semiconductor industry has experienced a sharp decline in orders and revenue. The outlook for the electronics industry is uncertain and we cannot predict how long the current downturn will last. Many semiconductor manufacturers and vendors of products incorporating semiconductors continue to announce earnings shortfalls and employee layoffs.
Budget cuts have impacted the number of orders we receive from our customers and some of our customers have been seeking larger discounts, extended payment terms or purchasing time-based licenses in lieu of more costly perpetual licenses. We believe our customers and potential customers internal budgets are currently subject to heightened scrutiny and the time required to receive budgetary approvals is lengthening. We cannot predict whether purchases of licenses of our software will be deferred due to budget constraints or whether the number of complex nanometer-scale semiconductor design starts by our customers will slow or decline.
30
If we lose any of our key personnel, our ability to manage our business and continue our growth would be negatively impacted.
Our future success depends in part on our ability to enhance our existing products and achieve market acceptance of new, innovative products and technologies. Our software and technologies are complex and to successfully implement our business strategy and manage our business, an in depth understanding of circuit design and the physical behavior of complex nanometer-scale semiconductors is required. We depend substantially on the expertise of Sang S. Wang, our Chairman and Chief Executive Officer, and our existing engineering personnel, especially An-Chang Deng, our President, and our other founders: Walter Chan, Iouri Feinberg, Andrei Tcherniaev and Jeh-Fu Tuan. We do not have long-term employment agreements with our founders and the loss of the services of any of our key employees could adversely affect our business and slow our product development process. We do not maintain key person life insurance on any of our employees. Further, four of our executive officers have agreed to work without receiving salary during fiscal 2002 and 2003. If any or all of these executive officers must be replaced, we would incur unexpected expenses relating to the payment of salaries to the replacement executive officers during fiscal 2003.
If we do not continue to expand our sales force and customer service and support organization, our revenue may not grow.
Approximately 74.6% of our total revenue in the six months ended March 31, 2003, 72.1% of our total revenue in fiscal 2002 and 61.2% of our total revenue in fiscal 2001 were from our direct sales efforts. Our software requires sophisticated sales efforts by experienced and knowledgeable personnel. Competition for these individuals is intense due to the limited number of people available with the necessary sales experience and technical understanding of electronic design automation products. Hiring customer service and support personnel is also very competitive in our industry due to the limited number of people available with the necessary technical skills. Our sales and support staff consisted of 49 persons as of March 31, 2003. If we are unable to successfully train and integrate sales and support personnel and continue to identify, hire, train and retain new qualified individuals, our revenue may not grow.
If we are unable to attract and retain qualified research and development personnel, our business will suffer.
There are a limited number of qualified software engineer and research and development personnel with the necessary experience and understanding of complex nanometer-scale semiconductor design products in the San Francisco Bay Area, where our primary facility is located. The scarcity of qualified persons may cause us to incur higher salary costs or require us to provide larger stock option grants. We recently opened a small research and development facility in Taiwan, out of which four of our engineers currently operate, to broaden the pool of software engineers from which we can recruit. We cannot assure you that this strategy will help us satisfy our need for qualified personnel. Further, we may encounter other difficulties with managing geographically separate research and development activities. If we fail to attract, motivate and retain engineers and research and development personnel, we may be unable to develop or enhance our software or meet the demands of our customers in a timely manner and our business would suffer.
Because we rely on distributors for a large portion of our revenue, our revenue could decline if our existing distributors do not continue to purchase software licenses from us.
A majority of our sales outside North America and Europe are conducted through distributors. Sales by our distributors accounted for approximately 25.4% of our total revenue in the six months ended
31
March 31, 2003, 27.9% of our total revenue in fiscal 2002 and 38.8% of our total revenue in fiscal 2001. We rely on Marubeni Solutions Corp. as the exclusive distributor of our software in Japan. Sales to Marubeni Solutions accounted for 14.5% of our total revenue in the six months ended March 31, 2003, 11.3% of our accounts receivable at March 31, 2003, 19.4% of our total revenue in fiscal 2002 and 23.0% of our accounts receivable at September 30, 2002. We cannot be certain that we will be able to attract distributors that market our software effectively or provide timely and cost effective user support and service. Further, our agreements with our distributors provide exclusive distribution rights, but do not obligate the distributor to purchase any amount of licenses of our software or sell licenses of our software. Consequently, one or more of our distributors may not continue to represent our software or devote a sufficient amount of effort and resources to selling our licenses of software in their territories. We may from time to time be forced to terminate relationships with distributors who do not maintain an appropriate level of sales. This could cause our sales in a given territory to decrease substantially or completely until a suitable replacement distributor can be found. In the past, we have terminated our relationships with certain distributors for poor performance. Even if we are successful in selling licenses of our software through new distributors, the rate of growth of our total revenue could be harmed if our existing distributors do not continue to sell licenses of our software or our new distributors are not quickly and effectively trained to sell licenses of and support our software.
If we fail to adequately match our expenses to anticipated revenue in any given quarter, our operating results could fall below market expectations and cause the price of our stock to decline.
Because of the seasonal fluctuations in our business, cyclicality of the semiconductor industry and the rapidly evolving market for complex nanometer-scale semiconductors, our ability to accurately forecast our quarterly revenue is limited. As a result, it is difficult to predict the revenue we will recognize in any given quarter.
We expect to experience seasonal fluctuations in our revenue due to:
| capital budgeting and purchasing cycles of our customers; |
| economic incentives for our sales force; |
| lengthening of the sales cycle due to limited resources as a result of layoffs by our customers, longer approval process, summer holidays, particularly in Europe and Japan; and |
| the number of orders received for perpetual licenses versus time-based licenses. |
Commissions represent a significant portion of our sales force compensation, which is structured to encourage sales closures prior to fiscal year end. As a result, we expect that sales efforts will intensify in the fourth fiscal quarter, which could result in our revenue being flat or slightly lower in the first quarter of the subsequent fiscal year.
It is difficult for us to evaluate the degree to which these factors may reduce our sales because our revenue growth historically had masked the impact of these factors. In addition, most of our costs are relatively fixed in the short term and our business may not grow rapidly enough to absorb the costs of our personnel and facilities. As a result, we may be unable to reduce our expenses to avoid or minimize the negative impact on our quarterly operating results if anticipated revenue is not realized. For example, for the three months ended March 31, 2003, our revenue and earnings fell short of our previous guidance and market
32
expectation, which negatively impacted the trading price of our common stock. These trends could materially affect our quarter to quarter operating results, which could negatively impact our stock price.
We may not succeed in creating market acceptance for LEXSIM, CRITIC AND HANEX, and our operating results may decline as a result.
We released our second major product, LEXSIM, in May 2002, our third product, CRITIC, in December 2002 and our fourth product, HANEX, in May 2003. To date, LEXSIM and CRITIC have accounted for only an immaterial portion of our revenues. Even though we do not expect LEXSIM, CRITIC or HANEX to account for a meaningful percentage of our total revenue until fiscal 2004, our future growth and profitability could be affected by our ability to increase sales of these new products. Furthermore, marketing new products requires significant additional expenses and resources. If we fail to market them successfully, our profitability may decline.
If we fail to enhance our circuit simulation and analysis software and develop and introduce new circuit simulation and analysis software on a timely basis, we may not be able to address the needs of our customers, our technology may become obsolete and our results of operations may be harmed.
The electronic design automation software market is characterized by rapid technological change, frequent new product introductions and enhancements, uncertain product life cycles, changes in user demands and evolving industry standards. The introduction of software embodying new technologies and the emergence of new industry standards can render existing software in the semiconductor design industry obsolete and unmarketable. For instance, if customers widely adopt new engineering languages to describe their semiconductor designs and our software fails to support those languages adequately, demand for our software will suffer. To be successful, we must devote a substantial amount of our resources to enhance HSIM, keep pace with changes within our industry and develop and market new technologies. If our enhanced products or our future products and technologies do not achieve market acceptance, we may not be able to maintain our market share or recoup our development costs. As a result, our operating results would be harmed.
Our sales cycle is unpredictable and may be more than six months, so we may fail to adequately match our expenses to anticipated revenue in any given period or meet market expectations.
Our sales cycle, or the period between our initial contact with a potential customer and the customers purchase of a license of our software, generally ranges from three to six months but may be longer, particularly in the current economic downturn. We cannot predict the exact length of our sales cycle, which at times has exceeded six months. The unpredictability of our sales cycle makes it difficult to plan our expenses and forecast our results of operations for any given period. If we do not correctly predict the timing of our customers purchases, the amount of revenue we recognize in a given quarter could be negatively impacted, which could harm our operating results. Our sales cycle may lengthen because of several factors, including:
| long technical evaluation periods and validation periods for the integration of our software with our potential customers existing semiconductor design flow; |
| the significant investment of resources required by customers to purchase and integrate our software into their design flow, particularly customers with large semiconductor design organizations; |
33
| competition from other electronic design automation software vendors; |
| limited and decreased capital spending due to weakness in the semiconductor industry and customers uncertainty about economic conditions; |
| limited access to key decision makers of potential customers to authorize the adoption of our software; |
| budget cycles of our customers which affect the timing of purchases; and |
| delay of purchases due to aggressive pricing discounts by our competitors and announcements or planned introductions of new products by our competitors or us. |
If we were to experience a delay in our orders, it could harm our ability to meet our forecasts or investors expectations for a given quarter and ultimately result in the decrease of our stock price. Further, if our sales cycle unexpectedly lengthens in general, it would adversely affect the timing of our revenue recognition, which could cause us not to meet market expectations and cause our stock price to suffer.
Our expansion into international markets will result in higher personnel costs or distributor commissions and could reduce our operating margins.
In order to penetrate international markets further, we must either expand the number of distributors who sell licenses of our software or increase our direct international sales presence. As we increase our direct international sales presence, our sales efforts may be delayed as we begin our local sales activities and we may incur higher personnel costs that may not result in additional revenue. These costs and the time to establish a local sales presence could harm our operating results. We may not realize corresponding growth in operating margins from growth in international sales due to the higher costs of these sales. We have increased our sales and support resources in Europe over the last 18 months and have established offices in France, Germany, United Kingdom and Israel. However, the expected returns on those investments have not been realized, primarily due to the economic slowdown. To date, we have relied primarily on international distributors in Asia and have only recently begun to employ direct sales personnel in Singapore and India. Even if we expand our direct and indirect international selling efforts, our efforts may not create or increase international market demand for our software or generate revenue sufficient to recoup the cost of this expansion.
If we experience losses in the future, the market price of our common stock could decline.
Although we had net income for the past 14 quarters, we may incur losses in the future. In order to fund our operations and implement our strategies, we must continue to increase our investment in research and development, sales and marketing and other operations. As a result, we will need to generate significant revenue to maintain profitability. If we do not maintain profitability, the market price of our common stock may decline, perhaps substantially.
We anticipate that our expenses will increase substantially in the next 12 months as we:
| increase our sales and marketing activities, particularly by expanding our direct sales force; |
| continue to increase the size and number of locations of our support organization; |
| continue to invest in research and development to enhance our existing products and technologies and develop new circuit simulation and analysis products; |
34
| implement additional internal systems, develop additional infrastructure and hire additional management to keep pace with our growth; and |
| continue to defend ourselves vigorously against the two lawsuits brought by Synopsys. |
Any failure to significantly increase our revenue as we implement our strategies would also harm our ability to maintain profitability and could negatively impact the market price of our common stock.
If we are not able to preserve the value of our softwares intellectual property, our business will suffer.
Our software is differentiated from that of our competitors by our internally developed technology. If we fail to protect our intellectual property, other vendors could sell circuit simulation and analysis software with capabilities similar to ours, and this could reduce demand for our software. We protect our intellectual property through a combination of copyright, patent, trade secret and trademark laws. We have only recently commenced a patent program and to date have filed two patent applications which have not been issued. We generally enter into confidentiality or license agreements with our employees, consultants and corporate partners, and generally seek to control access to our intellectual property and the distribution of our software, documentation and other proprietary information. However, we believe that these measures afford only limited protection. Others may develop technologies that are similar or superior to our technology or design around the copyrights and trade secrets we own. Unauthorized parties may attempt to copy or otherwise obtain and use our software or technology. Policing unauthorized use of our software is difficult and expensive, and we cannot be certain that the steps we have taken will prevent misappropriation of our technology, particularly in foreign countries where the laws may not protect our proprietary rights as fully as those in the United States. If our means of protecting our proprietary rights is inadequate or ineffective, our business may be severely harmed.
A protracted infringement claim or a significant damage award would adversely impact our operating results.
Substantial litigation and threats of litigation regarding intellectual property rights exist in our industry. We expect that circuit simulation and analysis design software may be increasingly subject to third-party infringement claims as the number of competitors in our industry segment grows and the functionality of products in different industry segments overlaps. We are not aware of any valid proprietary rights of third parties that our software infringes. We are currently a defendant in two lawsuits brought by Synopsys. Additional third parties other than Synopsys may claim that we infringe their intellectual property rights. Any claims, with or without merit, could:
| be time consuming to defend; |
| result in costly litigation and/or damage awards; |
| divert our managements attention and resources; |
| cause customers to cancel or delay orders; |
| cause product shipment delays; or |
| require us to seek to enter into royalty or licensing agreements. |
These royalty or licensing agreements may not be available on terms acceptable to us, if at all. A successful claim of product infringement against us or our failure to license the infringed or similar
35
technology could adversely affect our business. We would not be able to sell licenses of the impacted software without exposing ourselves to litigation risk and damages or we may be required to redevelop the software and incur significant additional expense. Because we expect to derive substantially all of our revenue from HSIM in fiscal 2003 and likely in fiscal 2004, anything that would limit our ability to license HSIM would harm our business.
Any potential dispute involving our intellectual property could include our customers and strategic partners, which could trigger our indemnification obligations with them and result in substantial expense.
In any potential dispute involving our intellectual property, our customers and strategic partners could also become the target of litigation. This could trigger our technical support and indemnification obligations in our license agreements, which could result in substantial expense to us. In addition to the time and expense required for us to supply such support or indemnification to our customers and strategic partners, any such litigation could severely disrupt or shut down the business of our customers and strategic partners, which in turn could hurt our relations with our customers and strategic partners and cause licenses for our software to decrease.
Significant errors in our software or the failure of our software to conform to specifications could result in our customers demanding refunds from us or asserting claims for damages against us.
Because our circuit simulation and analysis software is complex, our software could fail to perform as anticipated. Further, errors in our software may be found in the future. The detection of any significant errors may result in:
| product liability claims or damage awards; |
| the loss of or delay in market acceptance and sales of our software; |
| injury to our reputation and hindered market acceptance of our software; |
| diversion of development resources from new software to fix errors in existing software; |
| costs of corrective actions or returns of defective software; |
| reduction in maintenance or time-based license renewal rates; or |
| delays in shipping dates for our software. |
We have warranted that our software will operate in accordance with our user documentation. If our software fails to conform to these specifications, customers could demand a refund for the purchase price or assert and collect on claims for damages.
Moreover, because our software is used in connection with other vendors products that are used to design complex nanometer-scale semiconductors, significant liability claims may be asserted against us if our software does not work properly individually or with other vendors products. Our agreements with customers typically contain provisions intended to limit our exposure to liability claims. However, these limitations may not preclude all potential claims and we have only minimal insurance against such liabilities. Regardless of their merit, liability claims could require us to spend significant time and expense in litigation and divert managements attention from other business pursuits. If successful, a product liability claim could
36
require us to pay significant damages. Any claims, whether or not successful, could seriously damage our reputation and our business.
Because our strategy to expand our international operations is subject to uncertainties, we may not be able to enter new markets outside North America or generate a significant level of revenue from those markets.
Customers outside North America accounted for 38.8% of our total revenue in the six months ended March 31, 2003, 42.0% of our total revenue in fiscal 2002 and 51.0% of our total revenue in fiscal 2001. We plan to increase our international sales activities, but we have limited experience marketing and directly licensing our software internationally.
We have sales offices in France, Germany, Israel and the United Kingdom, and primarily rely on indirect sales in Asia. Although our sales contracts provide for payment for our software licenses in United States dollars, our expenses incurred in foreign locations are generally denominated in the applicable local currency. To date we have not undertaken any foreign currency hedging transactions, and as a result, our future expense levels from international operations may be unpredictable due to exchange rate fluctuations. Our international operations are subject to other risks, including:
| the impact of recessions in economies outside North America; |
| difficulties and costs of staffing and managing foreign operations; |
| foreign currency fluctuations; |
| reduced protection for intellectual property rights in some countries; |
| changes in import or export duties, quotas or controls, which could prevent us from shipping our software into markets outside North America; |
| greater difficulty in accounts receivable collection and longer collection periods; |
| unexpected changes in regulatory requirements; |
| proper maintenance of corporate formalities by our foreign subsidiaries; |
| potentially adverse tax consequences, including the impact of expiry of tax holidays; and |
| political and economic instability. |
We intend to pursue strategic relationships but these efforts could substantially divert management attention and resources.
In order to establish strategic relationships with semiconductor technology leaders and leading electronic design automation tool providers, we may need to expend significant resources and will need to commit a significant amount of management time and attention, with no guarantee of success. We may be unable to establish key industry strategic relationships if any of the following occur:
| potential industry partners become concerned about our ability to protect their intellectual property; |
| potential industry partners develop their own solutions to address circuit simulation and analysis of complex nanometer-scale semiconductors; |
37
| our potential competitors establish relationships with industry partners with which we seek to establish a relationship; or |
| potential industry partners attempt to restrict our ability to enter into relationships with their competitors. |
We have only recently entered into our current strategic relationships. These relationships may not continue or be successful. We also may be unable to find additional industry partners that are suitable.
We may not be able to expand our proprietary technologies if we do not make acquisitions or investments or fail to successfully integrate the acquired companies with our business.
To expand our proprietary technologies, we may acquire or make investments in complementary businesses, technologies or products if appropriate opportunities arise. We may be unable to identify suitable acquisition or investment candidates at reasonable prices or on reasonable terms, or complete future acquisitions or investments, any of which could slow our growth strategy. We may have difficulty integrating the products, personnel, culture, ideologies or technologies of any acquisitions we might make. These difficulties could disrupt our ongoing business, distract our management and employees and increase our expenses. In addition, the key personnel of the acquired company may decide not to work for us and if our customers are uncertain about our ability to operate on a combined basis, they could delay or cancel orders for our software. Furthermore, we may have to incur debt or issue equity securities to pay for any future acquisition, the issuance of which would be dilutive to our existing stockholders. We also could have difficulty in assimilating the acquired companys or divisions personnel and operations, which could negatively affect our operating results.
Our recent growth has placed a significant strain on our management systems and resources and we may be unable to effectively control our costs and implement our business strategies as a result.
We recently experienced a period of growth. Our total number of employees increased from 80 as of March 31, 2002 to 106 as of March 31, 2003. Our productivity and the quality of our software may be adversely affected if we do not integrate, train and motivate our new employees quickly and effectively. We also cannot be sure that our revenue will continue to grow at a sufficient rate to absorb the costs associated with the increased personnel.
We expect that any future growth we experience will continue to place a significant strain on our management, systems and resources. To manage the anticipated growth of our operations, we will be required to:
| hire, train, manage and retain additional qualified personnel, especially software engineers and sales staff; |
| improve existing and implement new operational, financial and management information controls, reporting systems and procedures; |
| maintain a high level of customer service and support; and |
| establish relationships with additional corporate partners and maintain our existing relationships. |
38
The markets for complex nanometer-scale semiconductors are evolving rapidly and if these markets do not develop and expand as we anticipate, the demand for our software and our revenue would decline.
We expect that a substantial majority of our revenue will continue to come from sales of HSIM in fiscal 2003. We depend on the growing use of circuit simulation and analysis software to design complex nanometer-scale semiconductors for use in portable consumer electronics, networking equipment and other applications. The market for complex nanometer-scale semiconductors may not grow if customers choose to use other types of semiconductors that might be more affordable or available with shorter time-to-market schedules. This could cause electronic equipment manufacturers to limit the number of new complex nanometer-scale semiconductors they design and would reduce their need for our software. If demand for our software were to decline, we may choose to lower the prices of our software or we may sell fewer licenses and have lower maintenance renewal rates. In addition, if equipment manufacturers do not widely adopt the use of complex nanometer-scale semiconductors or if there is a wide acceptance of alternative semiconductors that provide enhanced capabilities, the market price of our stock could decline due to our lower operating results or investors assessment that the growth potential for licenses of our software is limited.
The markets for complex nanometer-scale semiconductors are evolving rapidly and we cannot predict their potential sizes or future growth rates. Our success in generating revenue in these evolving markets will depend on, among other things, our ability to:
| educate potential customers about the benefits of complex nanometer-scale semiconductors and the use of our software to design them; |
| establish and maintain relationships with leading semiconductor manufacturers, electronic equipment designers, portable consumer electronic manufacturers, networking equipment and other electronics companies; |
| utilize our research and development efforts to anticipate and adapt to evolving markets; and |
| predict and base our software on technology that ultimately becomes industry standard. |
We face competition from internally developed semiconductor design software and if our customers elect to continue to use internally designed tools, our business may suffer.
We face significant competition from internal design software groups of semiconductor manufacturers. These internal groups compete with us for access to potential customers circuit simulation and analysis software budgets and may eventually compete with us to supply circuit simulation and analysis software to other semiconductor manufacturers. We cannot assure you that internal groups will not expand their internally designed tools to compete directly with ours or actively sell their internally designed tools to other semiconductor manufacturers or, if they do, that we will be able to compete against them successfully.
Our revenue could be reduced if large electronic design automation companies make acquisitions in order to utilize their extensive distribution capabilities with our competitors products.
Large electronic design automation vendors, such as Cadence Design Systems, Inc., Mentor Graphics or Synopsys, may acquire or establish cooperative relationships with our other current competitors, including private companies. For example, Synopsys acquired Avant! Corporation, a provider of a wide range of electronic design automation products, in June 2002. Because large electronic design automation vendors have significant financial and organizational resources, they may be able to further penetrate our markets by
39
leveraging the technology and expertise of smaller companies and utilizing their own extensive distribution channels. We expect that the electronic design automation product industry will continue to consolidate. For example, Mentor Graphics completed a cash tender offer for IKOS Systems, Inc., a functional verification company, in March 2002, and for Innoveda, Inc., an electronic design automation company, in May 2002. Additionally, Cadence Design Systems, Inc. completed its acquisition of Plato Design Systems, Inc., a design technology company, in April 2002, Simplex Solutions, a provider of software and services for the design and verification of integrated circuits, in June 2002, and Celestry Design Technologies, Inc., a provider of silicon modeling and circuit simulation tools, in January 2003, and entered into a definitive agreement to acquire Get2Chip, Inc., a provider of advanced nanometer-scale synthesis technology, in April 2003. It is possible that new competitors or alliances among competitors may emerge and rapidly acquire significant market share, which would harm our business and financial prospects.
We may not be able to compete effectively if our software is delayed or does not incorporate new required features.
Our future success depends on our ability to enhance existing software, develop and introduce new products, satisfy user requirements, meet industry standards and achieve market acceptance. We may not successfully identify new product opportunities or develop and bring new products to market in a timely and cost effective manner. Significant delays in our new software releases or significant problems or delays in enhancing existing products to keep pace with new design techniques for complex nanometer-scale semiconductors could seriously damage our business. We have, from time to time, experienced delays in the scheduled introduction of new and enhanced software and we may experience similar delays in the future. For example, in early 2001 we experienced delays in the development of a new product, which caused us to revise our expected release date for this product by several months. More recently, we have also delayed the release of another product in order to allow for an extended beta testing period. We cannot assure you that we will not experience additional difficulties that could delay or prevent the successful development, introduction and marketing of this software or that our new software and product enhancements will achieve market acceptance. If we are unable to develop, introduce and successfully market new or enhanced software in a timely manner in response to changing market conditions or customer requirements, our business, operating results and financial condition may be harmed.
We may sell fewer licenses of our products if other vendors products are no longer compatible with ours.
Our ability to sell licenses of our software depends in part on the compatibility of our software with other vendors software and hardware products. These vendors may change their products so that they will no longer be compatible with our software. If that were to happen, our business and future operating results would suffer if we were no longer able to offer commercially viable or competitive products.
We do not have a consulting staff, and our revenue may suffer if customers demand extensive consulting or other support services.
Our software is designed to be deployed quickly and easily by our customers and to require limited support from us. Many of our competitors offer extensive consulting services in addition to circuit simulation and analysis products. If we introduce software that requires extensive consulting services for specific designs, or if our customers wish to purchase a broad spectrum of software and services that includes extensive consulting services from a single vendor, we would be required to change our business model and cost structure to provide consulting services. Specifically, we would be required to hire and train consultants
40
or outsource the required consulting services. If these events were to occur, our future gross margin would likely suffer because of the added expense of hiring and retaining consulting personnel.
Our common stock is subject to substantial price and volume fluctuations due to a number of factors, many of which are beyond our control, and those fluctuations may prevent our stockholders from reselling our common stock at a profit.
The securities markets have experienced extreme price and volume fluctuations recently and the market prices of the securities of technology companies have been especially volatile. This market volatility, as well as general economic or political conditions, could reduce the market price of our common stock regardless of our operating performance. In addition, our operating results could be below the expectations of investment analysts and investors and, in response, the market price of our common stock may decrease significantly and prevent investors from reselling their shares of our common stock at or above the price at which they purchased the shares. For example, in April 2003 we reported our financial results for the three months ended March 31, 2003, which were below previous guidance and market expectations. As a result, the stock price of our common stock was adversely impacted. In the past, companies that have experienced volatility in the market price of their stock have been the subject of securities class action litigation. If we were the subject of securities class action litigation, it could result in substantial costs, liabilities and a diversion of managements attention and resources.
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
We develop products primarily in the United States and sell those products primarily in North America, Europe and Japan. Our revenue for sales outside of North America was approximately 37.9% in the three months ended March 31, 2003, 42.7% in the three months ended March 31, 2002, 38.8% in the six months ended March 31, 2003 and 45.7% in the six months ended March 31, 2002. As a result, our financial results could be affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. As all of our sales are currently made in United States dollars, a strengthening of the United States dollar could make our software less competitive in foreign markets.
Our interest income is sensitive to changes in the general level of United States interest rates, particularly since the majority of our investments are in short-term instruments. We expect that our interest income will be negatively affected by recent declines in short-term interest rates. A sensitivity analysis assuming a hypothetical 10% movement in interest rates applied to our cash equivalent and short-term investments balances at March 31, 2003 would change interest income by approximately $100,000 on an annual basis. However, due to the nature of our short-term investments, we have concluded that we do not have material market risk exposure.
We invest funds in excess of current operating requirements in short-term tax exempt and taxable instruments that meet high credit quality standards, as specified in our investment policy. The policy also limits the amount of credit exposure to any one issue, issuer or type of instrument. As of March 31, 2003, our cash, cash equivalents and short-term investments primarily consisted of the following instruments:
| obligations of the United States government and its agencies; |
| investment grade state and local government obligations; |
| securities of United States corporations rated A1 or P1 by Standard & Poors or Moodys equivalents; and/or |
41
| money market funds, deposits or notes issued or guaranteed by United States and non-United States commercial banks meeting certain credit rating and net worth requirements with maturities of less than one year. |
ITEM 4. | CONTROLS AND PROCEDURES |
(a) | Evaluation of disclosure controls and procedures. |
Within the 90 days prior to the filing of this Quarterly Report on Form 10-Q (the Evaluation Date), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a- 14(c) and 15d-14(c) under the Exchange Act). Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures are effective to ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. It should be noted, however, that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.
(b) | Changes in internal controls. |
Subsequent to the Evaluation Date, there have been no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their last evaluation.
PART IIOTHER INFORMATION
ITEM 1. | LEGAL PROCEEDINGS |
Synopsys has filed claims against us in state and federal court. These claims are based on the alleged facts and circumstances relating to the departure of our five founders from their employment at Synopsys, the founding of our company and the development and sale of HSIM and our other products. Each of our founders and Dr. Sang S. Wang, our Chief Executive Officer, became an employee of Synopsys when Synopsys acquired EPIC Design Technology in February 1997. Dr. Wang resigned from Synopsys in March 1998 and served as a consultant to Synopsys until June 1998. Dr. An-Chang Deng, our President, and our four other founders resigned from Synopsys at approximately the same time in August 1998 and became employees of our company immediately thereafter. Dr. Wang became an employee of our company in April 1999. None of Drs. Wang or Deng or our four other founders was subject to a noncompetition agreement with Synopsys at any time.
In February 2000, Synopsys filed a complaint in the Superior Court of the State of California in the County of Santa Clara (Case No. CV787950) against us and Dr. Deng, our President. The complaint alleged breach of contract, breach of fiduciary trust, diversion of corporate opportunity and constructive trust. In September 2001, Synopsys filed its second amended complaint, which added claims of inducing/aiding and abetting breach of fiduciary duty, including/aiding and abetting diversion of corporate opportunity, misappropriation of trade secrets, civil conspiracy, breach of confidence and unfair competition, and added as individual defendants Dr. Wang and our four other founders. In September 2002, Synopsys filed a supplemental second amended complaint that contained supplemental allegations but added no new claims or parties. In January 2003, the discovery referee issued orders creating rebuttable presumptions in favor of Synopsys on certain evidentiary issues to sanction us for erasure of certain computer files requested in discovery by Synopsys. These rulings mean that we must prove at trial that we did not take or use Synopsys source code or other confidential information, rather than the usual requirement that Synopsys provide such
42
proof in the first instance. However, none of these rulings resolves any of the claims made by Synopsys in the case and the trial judge or jury can reach their own conclusions based upon the evidence presented at trial. We filed a motion for reconsideration of this order and in March 2003, the Court denied our motion, concluding that it was barred on procedural grounds. In January 2003, Synopsys filed a third amended complaint, which contained supplemental allegations but added no new claims or parties. We have filed an answer denying Synopsys allegations. This action is currently in discovery. Synopsys has requested unspecified damages of at least $25 million, an injunction, a constructive trust on unspecified intellectual property belonging to us and other relief. A trial date has not yet been set.
We believe that we have meritorious defenses to Synopsys allegations and claims and we intend to continue to defend ourselves vigorously. However, because of the inherent uncertainty of litigation in general, and the fact that the discovery related to this litigation is ongoing, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we could be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. Although the final outcome of the litigation may not occur for some time, the parties periodically conduct evidence gathering, meet to discuss the status of the litigation and file motions and other requests for the court to act. The results of these periodic activities, particularly the courts decisions on current pending and future motions, could have the effect of determining the ultimate outcome of the litigation, either for or against us, prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. For example, in November 2001, the court denied a motion brought by Synopsys for injunctive relief that, if granted, could have prevented us from selling our products. If any of Synopsys motions ultimately prevail, our ability to defend ourselves against the claims brought against us in this litigation could be severely limited. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the Synopsys litigation. Accordingly, an adverse judgment, if entered in favor of any Synopsys claim, could seriously harm our business, financial position and results of operations can cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
In May 2001, Synopsys filed a complaint in the United States District Court, Northern District of California, San Jose division (Case No. CO1-20423 PVT) against us, alleging that our HSIM software infringes Synopsys U.S. Patent No. 5,878,053 entitled Hierarchical Power Network Simulation and Analysis tool for reliability testing of Deep Submicron IC Designs (the 053 patent). Since the case began, Synopsys has also alleged that our subsequently released HSIM 2.0 and LEXSIM products, infringe the 053 patent. Synopsys has requested relief including damages from $4.1 million to $13.7 million and an injunction. Synopsys has also requested that any damage award be trebled for alleged willful infringement. In June 2001, we filed an answer to the complaint denying infringement of a valid, enforceable patent and asserting counterclaims. We have since amended our counterclaims. Our current counterclaims allege that, among other things, the 053 patent is invalid, unenforceable and not infringed and that Synopsys has violated federal antitrust and state unfair competition laws.
43
From time to time, the court has ruled on summary judgment motions in the case. In May 2002, the court granted summary judgment in favor of Synopsys on our invalidity defenses and counterclaims, concluding that they were barred by the doctrine of assignor estoppel. The court denied Synopsys motion with respect to our unenforceability defense and counterclaim. In November 2002, the court issued an order granting summary judgment in favor of Synopsys on certain antitrust counterclaims based on the doctrine of assignor estoppel. However, the court declined to rule on Synopsys motion with respect to our other antitrust and unfair competition counterclaims. In addition, the court issued a ruling construing the claims of the 053 patent in August 2002.
In September 2002, the U.S. Patent and Trademark Office granted our request for ex parte reexamination of the 053 patent based on prior art not previously considered by the Patent Office. We have moved to stay the federal litigation pending the outcome of the reexamination and the court granted our motion in December 2002. During the reexamination of the 053 patent, the Patent Office may determine that the subject matter in the patent is patentable as originally claimed, that the subject matter is patentable if the claims are modified or that the subject matter is not patentable. We cannot predict what the result of the reexamination procedure will be or how long it will take to complete.
Activity on several other summary judgment motions has been suspended because the court stayed the federal litigation. In November 2002, Synopsys filed three motions for summary judgment. The first motion asked the court to enter judgment before trial that Nassdas products infringe the 053 patent. The second motion asked the court to rule before trial against us on our defense that the 053 patent is unenforceable because Synopsys committed inequitable conduct in obtaining the patent. We submitted oppositions to both of these motions. Synopsys third motion asked the court to rule before trial against us on our remaining antitrust counterclaims. Because of the courts prior rulings against us on our other antitrust counterclaims, we did not oppose this motion. In November 2002, we also filed a summary judgment motion, which asked the court to enter judgment before trial that our products do not infringe the 053 patent. Synopsys opposed this motion. The Court issued its order staying the federal litigation before the parties reply briefs were due.
We believe we have meritorious defenses to Synopsys claims and intend to defend ourselves vigorously. However, because of the high degree of complexity of the intellectual property at issue, the inherent uncertainties of litigation in general and the preliminary nature of this litigation, we cannot assure you that we will ultimately prevail. Should Synopsys ultimately succeed in the prosecution of its claims, we could be permanently enjoined from selling our software and deriving related maintenance revenue. In addition, we may be required to pay substantial monetary damages to Synopsys. Further, we could be enjoined preliminarily from selling our software during the course of the litigation. Litigation such as the suit Synopsys has brought against us can take years to resolve and can be expensive to defend. The courts decisions on current pending and future motions could have the effect of determining the ultimate outcome of the litigation prior to a trial on the merits, or strengthen or weaken our ability to assert claims and defenses. It is possible that our relationships with our customers will be seriously harmed in the future as a result of the Synopsys litigation. Accordingly, an adverse judgment, if entered on any Synopsys claim, could seriously harm our business, financial position and results of operations and cause our stock price to decline substantially. In addition, the Synopsys allegations and claims, even if ultimately determined to be without merit, could be time consuming to defend, result in costly litigation, divert our managements attention and resources, cause product shipment delays or require us to enter into royalty or license agreements. These royalty or license agreements may not be available on terms acceptable to us, if at all, and the prosecution of the Synopsys allegations and claims could significantly harm our business, financial position and results of operations and cause our stock price to decline substantially.
44
ITEM 4. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
At the Annual Meeting of Stockholders held on February 25, 2003, of the 25,425,093 shares of Nassda capital stock entitled to vote at the meeting, 22,526,404 were present in person or by proxy. The Nassda stockholders approved the following matters:
1. A proposal to elect two Class I directors of the Company to serve until the Annual Meeting of Stockholders in 2006, until their successors are duly elected and qualified or until their earlier resignation or removal.
Nominee |
Shares voted in favor |
Shares voted against |
Shares Withheld | |||
Yen-Son (Paul) Huang |
22,491,785 |
|
34,619 | |||
Sang S. Wang |
22,507,785 |
|
18,619 |
The Class II directors, An-Chang Deng and Bernard Aronson, and the Class III director, Edward C.V. Winn, will serve until the Annual Meeting of Stockholders in 2004 and 2005, respectively, until their respective successors are duly elected and qualified or until their earlier resignation or removal.
2. A proposal for the ratification of the appointment of Deloitte & Touche LLP as independent public accountants of the Company for the fiscal year ending September 30, 2003 was approved by a vote of 22,442,430 for, 83,149 votes opposed and 825 votes withheld.
3. A proposal for the approval of the option grant limitations contained in the Companys 2001 Stock Option Plan for the purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended, was approved by a vote of 21,206,152 for, 1,319,277 votes opposed and 975 votes withheld.
ITEM 6. | EXHIBITS AND REPORTS ON FORM 8-K |
(a) | Exhibits |
Exhibit 99.1 |
Certification of Chief Executive Officer and Chief Financial Officer |
(b) | Reports on Form 8-K |
The Company filed a current report on Form 8-K on April 2, 2003 in connection with its earnings release.
45
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NASSDA CORPORATION | ||
By: |
/s/ SANG S. WANG | |
Sang S. Wang | ||
Chief Executive Officer and Chairman (Principal Executive Officer) | ||
By: |
/s/ TAMMY S. LIU | |
Tammy S. Liu | ||
Vice President of Finance and Administration and Chief Financial Officer (Principal Financial and Accounting Officer) |
46
I, Sang S. Wang, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Nassda Corporation; |
2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and |
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 13, 2003
/s/ SANG S. WANG Sang S. Wang Chief Executive Officer and Chairman of the Board |
47
I, Tammy S. Liu, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Nassda Corporation; |
2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: |
a) | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) | evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and |
c) | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. | The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: May 13, 2003
/s/ TAMMY S. LIU Tammy S. Liu Chief Financial Officer and Vice President, Finance and Administration |
48